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Abstract 
Two classes of secondary metabolites found in Brassica crops are of particular 
importance for eliciting human health benefits: phenolic compounds and glucosinolate 
hydrolysis products. These compounds have been demonstrated—among other things—to induce 
detoxification enzymes, mitigate inflammation, lower the risk of type II diabetes, and decrease 
cancer risk. In order to better utilize plants for the promotion of human health, a coordinated 
effort of advancement is needed in all related fields, including the genetic and environmental 
regulation of plant secondary product biosynthesis and the in vivo targets and mechanisms of 
action of phytochemicals in humans. This research addresses the genetic control of glucosinolate 
metabolism and phenolic compound accumulation in broccoli (Brassica oleracea L. var. italica). 
Gas chromatography was utilized to quantify glucosinolate hydrolysis products in the broccoli 
mapping population VI-158 × BNC. The same population was also evaluated for phenolic 
compound accumulation with three chemical assays: total phenolic content, ABTS radical 
scavenging capacity, and DPPH radical scavenging capacity. Quantitative trait loci analysis was 
employed for each of these phenotypes to identify genetic loci associated with variation in 
glucosinolate hydrolysis and phenolic compound accumulation. The genetic linkage map used 
for this analysis was saturated with single nucleotide polymorphism (SNP) markers anchored to 
the B. oleracea reference genome TO1000 (Brown et al. 2014). Physical markers were utilized to 
identify putative candidate genes underlying the QTL effects. This works reveals several 
questions for further investigation and the potential challenge of improving metabolites that are 
responsive to environmental conditions, but also highlights potential target genes for breeding 
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Chapter 1. Literature Review 
1.1 Rationale 
As the population in the developed world ages, the degenerative diseases associated with 
aging such as cancer and cardiovascular disease will continue to increase in prevalence. Finding 
ways to address these diseases is critical for reducing the burden of healthcare upon society and 
for the general promotion of quality of life for the aging. One potential avenue for combating 
carcinogenesis and degenerative diseases is by increasing the level of health-promoting 
phytochemicals in foods. To this end, research on the bioactive components of Brassica 
vegetables stands to play a critical role. 
Humans have utilized plants for centuries, not only for nutrition, but also for the 
treatment of disease. Many pharmacologically active compounds are natively produced in plants 
as secondary metabolites as a means for plants to mitigate abiotic and biotic stress (Herr and 
Buchler 2010). Enormous research efforts have been devoted to the characterization of 
phytochemicals that exhibit beneficial pharmacological effects in humans. Two classes of 
secondary metabolites found in Brassica crops are of particular importance for eliciting health 
benefits: phenolic compounds and glucosinolate hydrolysis products. These compounds have 
been demonstrated—among other things—to induce detoxification enzymes, mitigate 
inflammation, lower the risk of type II diabetes, and decrease cancer risk (Zhang et al. 1992; 
Elbarbry and Elrody 2011; Clifford 2004; Verhoeven et al. 1996; Herr and Buchler 2010). In 
order to better utilize plants for the promotion of human health, a coordinated effort of 
advancement is needed in all related fields, including the genetic and environmental regulation of 
plant secondary product biosynthesis and the in vivo targets and mechanisms of action of 
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phytochemicals in humans. This research addresses the genetic control of glucosinolate 
metabolism and phenolic compound accumulation in broccoli (Brassica oleracea L. var. italica).  
Study of the glucosinolate biosynthesis and metabolism pathways has thus far identified 
key genes, enzymes and cofactors involved in glucosinolate accumulation and breakdown. Since 
it is the hydrolysis products of the glucosinolates, especially the isothiocyanates (ITCs), which 
exhibit anticarcinogenic activity (Nastruzzi et al. 2000), crop improvement efforts necessarily 
must include enhancement in the conversion of glucosinolates to isothiocyanates. As human 
digestive enzymes and the gut microflora only hydrolyze a limited amount of glucosinolate, the 
native plant myrosinases are responsible for producing the majority of isothiocyanates available 
upon consumption (Conaway et al. 2000). Research on the activity of myrosinase and the 
partitioning of hydrolysis products between nitrile and ITC forms is, therefore, a critical 
component that must be addressed in order to achieve the development of broccoli cultivars with 
improved in vivo anticarcinogenic activity.  
The phenylpropanoid biosynthesis pathway has been well characterized due to the 
ubiquitous nature of phenolic compounds in plants and their biological importance in biotic and 
abiotic stress resistance, pigmentation, etc. (Cheynier et al. 2013).  Among the Brassica 
vegetables, there is great variation in the accumulation of phenolic compounds between species, 
subspecies, and cultivars (Heimler et al. 2006; Lin and Harnley 2010). However, the genetic 
control of phenolic accumulation has not been well studied within the context of vegetable crop 
improvement. Thus, there is a need for research that elucidates more of the genetic control 
behind phenolic compound accumulation in the edible tissues Brassica vegetables.  
The aim of this research was to quantify myrosinase activity and GS conversion to ITCs, 
as well as phenolic compound accumulation, in a broccoli mapping population known to contain 
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divergent phytochemical profiles. Subsequent QTL mapping and candidate gene investigation 
identified loci and genes of interest involved in the genetic regulation of the traits under review. 
The information resulting from this project should be beneficial for breeding efforts that seek to 
increase the health-promoting potential of Brassica vegetables by providing genetic parameters 
for selection. Gene information could be utilized both in traditional breeding programs for 
marker assisted selection or genomic selection for improved myrosinase activity and phenolic 
accumulation traits, and in the development of transgenic varieties. While it is recognized that 
environmental factors will still play a critical role in the regulation of plant secondary 
metabolites, greater knowledge of their genetic regulation stands to advance the goal of breeding 
vegetables with greater health-promoting capacity.  
1.2 Glucosinolates 
Glucosinolates (GSs) are secondary plant metabolites that are β-thioglucoside-N-
hydroxysulfates synthesized from amino acids (Travers-Martin et al. 2008). Plants capable of 
producing glucosinolates are almost exclusively from the order Brassicales; this order contains a 
number of important species such as the model plant Arabidopsis thaliana and economic 
Brassica sp. crops (broccoli, cabbage, kale, rapeseed etc.). The rich genetic information available 
from Arabidopsis coupled with strong interest in analyzing the bioactivity of GS metabolites as 
pest deterrents, anti-nutritive animal feed compounds, and cancer-preventing agents in humans 
has resulted in extensive and ongoing research characterizing their biosynthesis and metabolism 
(Halkier and Gershenzon 2006).  
The most recent critical review of identified glucosinolate compounds presents 200 
verified structures and an additional 180 theoretical structures extrapolated from known GSs. 
Individual plant species generally contain a small subset of GSs, typically on the order of two to 
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five compounds, though a collection Arabidopsis thaliana ecotypes has been reported to contain 
34 different GSs (Clarke 2010). Within the Brassica genus, approximately 30 different 
glucosinolates are reported (Bellostas et al. 2007). For a list of the glucosinolates commonly 
found in Brassica vegetables, see Table 1.1. All glucosinolate compounds are comprised of a 
common core structure of a β-D-glucopyranose attached to by a sulfur atom to a (Z)-N-
hydroximinosulfate ester (Fig. 1.1). A variable R group, derived from one of eight amino acid 
precursors, and the side-chain modifications distinguish each unique GS compound. A given 
glucosinolate can be placed into one of three categories based upon the amino acid it is made 
from. Indole GSs are derived from tryptophan, aromatic GSs from phenylalanine or tyrosine, and 
aliphatic GSs from alanine, leucine, isoleucine, valine or methionine (Halkier and Gershenzon 
2006). In A. thaliana and Brassica species, the primary glucosinolates that are synthesized are 
indoles derived from tryptophan (Wentzel et al. 2007) and aliphatics derived from methionine 
(Sotelo et al. 2014b). 
1.2.1 Glucosinolate Biosynthesis 
The elucidation of the glucosinolate biosynthesis pathway began in the 1960s with 
radiolabeled feeding studies, and has progressed through biochemical and genetic analyses to 
recent QTL and eQTL studies of biosynthesis-associated loci and genes (Halkier and Gershenzon 
2006; Fahey et al. 2001; Sotelo et al. 2014b; Wentzel et al. 2007). GS biosynthesis proceeds 
through three stages: (i) amino acid side-chain elongation, (ii) oxidative decarboxylation and 
rearrangement into the core glucosinolates structure, and (iii) secondary modification (Yan and 
Chen 2007). For a depiction of the GS biosynthesis pathway, see Figure 1.2. 
The chain elongation of methionine is initiated by deanimation, catalyzed by a branched-
chain amino acid aminotransferase (BCAT) enzyme, yielding a 2-oxo acid. The 2-oxo acid then 
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enters a three-step cycle in which condensation with acetylCoA, isomerization, and oxidative 
decarboxylation are successively catalyzed by a methylthioalkylmalate synthase (MAM), an 
isopropylmalate isomerase (IPMI), and an isopropylmalate dehydrogenase (IPM-DH). The result 
is a 2-oxo acid with an additional methylene group. At this point, transamination by a BCAT will 
produce an elongated methionine that may enter the core glucosinolate biosynthesis pathway. 
Alternatively, further elongation cycles may ensue prior to transamination, yielding an array of 
chain-lengths (Sønderby et al. 2010). 
In the core glucosinolate biosynthesis pathway, enzymes from the cytochrome P450 
family CYP79 catalyze the formation of aldoximes, which are further oxidized by CYP83s to 
aci-nitro or nitrile oxide compounds. This activation allows for non-enzymatic conjugation with 
a sulfur donor. The resulting S-alkylthiohydroximate is cleaved by the C-S lyase SUR1 to a 
thiohydroximate. S-glucosylation of the thiohyroximate generates a desulfoglucosinolate, a 
transformation facilitated by a glucosyltransferase from the UGT74 family. Finally, the 
desulfoglucosinolate is sulfated by a sulfotransferase (Sønderby et al. 2010). 
Secondary modifications to glucosinolates generate a diversity of structures and 
biological activities. Modification reactions for aliphatic glucosinolates include oxygenations, 
hydroxylations, alkenylations sinapoylations, and benzoylations, while indolic glucosinolates 
may undergo hydroxylations and methoxylations (Sønderby et al. 2010). Some important 
enzymes involved in secondary modifications have been identified, such as the flavin 
monooxygenases FMOGS-X1-5, which are responsible for S-oxygenation (Hansen et al. 2007; Li et 
al. 2008), and the 2-oxoglutarate-dependent dioxygenases AOP2 and AOP3. AOP2 catalyzes the 
formation of alkenyl glucosinolates, while AOP3 is responsible for the formation of 
hydroxyalkyl glucosinolates (Kliebenstein et al. 2001).  
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The regulatory network of GS biosynthesis incorporates signals from developmental and 
environmental stimuli and coordinates with the status of other critical metabolites such as indole 
acetic acid (the plant hormone auxin), which shares a common tryptophan-derived precursor 
with the indolic GSs. SLIM1 is a regulatory protein that represses glucosinolate biosynthesis and 
promotes GS catabolism in response to sulfur deficiency (Maruyama-Makashita et al. 2006). 
Wounding and herbivory induce AtDof.1 expression, which in turn up-regulates CYP83B1 and 
yields a moderate increase in both aliphatic and idolic GS levels (Skirycz et al. 2006).  
Some of the most important regulators of GS biosynthesis are R2R3-MYB transcription 
factors (TFs) from subgroup 12. For indolic GSs, the key regulators are MYB51, ATR1/MYB34, 
and MYB122. Overexpression and knockout mutant analysis in Arabidopsis revealed that 
MYB51 is the primary positive regulator of indolic GS biosynthesis, as it increased the 
accumulation of several indolic GS compounds. Overexpression of MYB122 enhanced the 
accumulation of indol-3-ylmethyl (I3M) glucosinolate—the primary product of the indolic GS 
pathway—and caused a mild increase in indole acetic acid (IAA), but only in the presence of a 
functional MYB51 (Gigolashvili et al 2007a). ATR1/MYB34 (ALTERED TRYPTOPHAN 
REGULATION 1) overexpression resulted in as much as sevenfold higher IAA levels compared 
to wild type, as well as increased indolic GS accumulation (Celenza et al. 2005). These 
chemotypes are well explained by the overlapping but distinct changes in gene expression 
affected by the three MYB TFs. Several important indolic GS biosynthesis genes early in the 
pathway (TSB1, CYP79B2, CYP79B3, and CYP83B1) are up-regulated by all three TFs. MYB34 
and MYB122 both activated ASA1 (anthranilate synthase), a tryptophan biosynthesis gene, 
explaining their altered IAA phenotypes. On the other hand, only MYB51 induced genes at the 
end of the indolic GS pathway such as UGT74B1 and AtST5a (Gigolashvili et al. 2009). The role 
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of these TFs in the overall GS regulatory network is at the point of direct induction of 
biosynthesis genes in response to incoming signals. Several studies have shown that MYB51 
expression is up-regulated in response to biotic challenges such as pathogen attack and wounding 
(Chen et al. 2002; Cheong et al. 2002; Gigolashvili et al 2007a). Domebrecht et al. (2007) 
showed that the stress-signaling hormone methyl jasmonate (MeJA) induced the expression of 
both MYB51 and MYB34; however, the jasmonate-signaling component MYC2/JIN1 acted as a 
negative regulator of MeJA-dependent MYB51 expression and as a positive regulator of MeJA-
dependent MYB34 expression. 
The aliphatic GS pathway is principally regulated by MYB28, MYB29, and MYB76. 
MYB28 is the primary regulator of both long and short-chain aliphatic GSs, showing the 
strongest trans-activation capacity towards target biosynthesis genes. MYB29 activation only 
increases short-chain aliphatic GSs; likewise for MYB76, although its role is more accessory as 
MYB76 is unable to induce GS biosynthesis in the absences of MYB28 and/or MYB29 
(Gigolashvili et al. 2009). The unique roles of theses TFs become more interesting upon 
investigation of the environmental signals to which they respond. MYB28 is activated by the 
application of glucose, demonstrating its role in integrating carbohydrate availability into the 
regulation of aliphatic GS biosynthesis (Gigolashvili et al. 2007b). MYB29 expression was 
increased several fold in response to exogenous MeJA application. Under normal growing 
conditions MYB76 has minimal effect upon aliphatic GS biosynthesis, but upon mechanical 
wounding, MYB76 expression increases by 50-fold and trans-activates MYB28/29, indicating its 




1.2.2 Glucosinolate Hydrolysis and Aglycone Rearrangement  
Following biosynthesis, glucosinolates are stable and not biologically active until they are 
hydrolyzed by a myrosinase [β-thioglucosidase glucohydrolase (EC 3.2.1.147)]. Myrosinases are 
hydrolytic enzymes that cleave the thioglucoside bond, releasing glucose and forming an 
unstable aglycone thiohydroximate-O-sulfonate (Travers-Martin et al., 2008). The hydrolysis of 
glucosinolates in healthy plant tissue occurs at a basal level due to the separate 
compartmentalization of glucosinolates and myrosinases.  
While the precise localization of glucosinolates and myrosinases differ between plant 
species and even organs or developmental stages within the same species, some general trends 
have emerged. Both glucosinolates and myrosinases are localized to vacuoles, but in separate 
cells. Myrosinase-containing cells, referred to as myrosin cells, do not accumulate 
glucosinolates, but are typically in close proximity to cells that accumulate glucosinolates, 
classically termed S-cells due to the high sulfur content of the glucosinolates (Kissen et al. 
2009). Upon wounding or cellular disruption, the vacuolar contents of these two cell types are 
brought into contact with each other, allowing for a burst of glucosinolate hydrolysis.  
The resulting aglycone then undergoes rearrangement and hydrogen sulfate release, 
which may result in a variety of products depending upon the pH (Gil and MacLeod 1980), 
ferrous ion concentration (Uda et al. 1986), the presence of the specifier proteins [e.g. 
epithiospecifier protein (ESP) and epithiospecifier modifier (ESM1)], and the structure of the 
aglycone (Yan and Chen 2007). The influence of specifier proteins on aglycone rearrangement 
will be detailed later. Under neutral pH the primary products are isothiocyanates, while in acidic 
conditions nitriles predominate. Glucosinolates with a terminal double bond produce 
epitionitriles in the presence of ESP. Other possible degradation products include thiocyanates 
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resulting from the hydrolysis of indolic and aromatic glucosinolates, and oxazolidine-2-thiones 
from hydroxylated glucosinolates (Chen and Andreasson 2001). For a diagram of glucosinolate 
hydrolysis, see Figure 1.3. 
Ecologically, some of these hydrolysis products serve as defense compounds, exhibiting 
toxicity towards various plant pathogens and generalist herbivores (Bednarek et al. 2009; Fan et 
al. 2011; Barth and Jander 2006). Conversely, GS hydrolysis products serve as feeding 
attractants and oviposition cues for specialists such as the cabbage white moth, Pieris rapae 
(Wittstock et al. 2003). In mammalian systems, study of the chemopreventive bioactivity of GS 
hydrolysis products has demonstrated that isothiocyanates are more potent anti-cancer agents 
than their respective nitriles (Nastruzzi et al. 2000). Sulforaphane, the isothiocyanate product of 
the glucosinolate glucoraphanin, has been most extensively studied (Herr and Buchler 2010).  
 Enhancing the production of isothiocyanates in crops requires an understanding not only 
of the accumulation of glucosinolate substrates, but also the activity of myrosinase. Myrosinase 
proteins in Brassica species are encoded by a family of genes divided into three subfamilies 
separated by protein size, sequence similarity, and differential expression across developmental 
stages and plant organs. Isoforms from the subfamily MA (Myr1) occur as free, soluble dimers, 
while isoforms from MB (Myr2) and MC exist bound in large molecular weight, insoluble 
protein complexes (Xue et al. 1992; Falk et al. 1995; Rask et al. 2000). Two distinct protein 
families that have been found to co-purify with myrosinase are myrosinase-binding proteins 
(MBPs) and myrosinase-associated proteins (MyAPs). The role of these proteins, however, is 
poorly understood, and the majority of MBP and MyAP annotations are not based upon protein 
characterization, but sequence homology (Kissen et al. 2009).  
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Arabidopsis has a relatively small family of six myrosinase genes (TGG1-6). TGG3 and 
TGG6 appear to be pseudogenes expressed specifically in floral tissues (Zhang et al. 2002; 
Kissen et al. 2009). TGG1 and TGG2 are expressed in the aerial tissues, while TGG4 and TGG5 
are expressed in roots.  Purified protein obtained from cDNA expression of TGG1, TGG4, and 
TGG5 in Pichia pastoris was utilized by Andersson et al. (2009) to perform enzyme activity 
characterization. Unique responses to temperature, pH, and salt concentrations were found for 
each myrosinase. All three myrosinase proteins showed activation by low concentrations (0.7-
1.0mM optimum) of ascorbic acid and inhibition at high concentrations. TGG1 showed the 
greatest activity at lower temperatures (20-40°C) and higher ascorbic acid concentrations, while 
TGG4 and TGG5 performed better at higher temperatures (70°C and 60°C, respectively), were 
less inhibited by high salt and low pH conditions, and showed less activation and a lower 
inhibition threshold with ascorbic acid (Andersson et al. 2009). This complexity in the 
myrosinase system is only compounded in species with a larger myrosinase gene family (e.g. 
Brassica napus with as many as 20 functional myrosinase genes (Kissen et al. 2009)).  
 The measurement of myrosinase activity has been conducted using assays against all of 
the compounds in the hydrolysis pathway except for the unstable thiohydroximate-O-sulfates. 
The reduction in glucosinolate may be observed by direct spectrophotometric assay (Palmieri et 
al. 1982), the release of hydrogen sulfate can be quantified by the pH-stat method (Piekarska et 
al. 2013), the release of glucose can be measured by enzyme-coupled spectrophotometric assay, 
and the mustard oil products can be measured directly by their spectrophotometric absorbance 
(Travers-Martin et al. 2008). In order to achieve more specific activity measurements with regard 
to the conversion of specific glucosinolates to specific hydrolysis products, Dosz et al. (2014) 
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utilized gas chromatography to quantify allyl isothiocyanate (AITC) and sulforaphane formation 
resulting from the hydrolysis of sinigrin and glucoraphanin, respectively. 
 Following the cleavage of the glycosidic bond by myrosinase, specifier proteins play an 
important role in directing the outcome of the aglycone rearrangement. Two important specifier 
proteins in Brassica vegetables are ESP and ESM1. ESP functions in an Fe(II) dependent 
manner to promote the formation of epithionitrile (or nitrile) hydrolysis products (Tookey 1973; 
MacLeod and Rossiter 1985; Lambrix et al. 2001; Zabala et al. 2005; Matusheski et al. 2006; 
Williams et al. 2010), while ESM1 epistatically diminishes ESP-directed nitrile formation and 
promotes the formation of isothiocyanates (ITCs) (Zhang et al. 2006).  
The mechanism of action for ESP and its interaction with myrosinase has not been fully 
elucidated, but there is evidence that suggests ESP has enzymatic activity rather than an 
allosteric effect on myrosinase. While a stable association between myrosinase and ESP has not 
been found with affinity chromatography, Burrow et al. (2006) showed that some proximity of 
ESP to myrosinase is required for the formation of nitriles because separation of the two proteins 
in a dialysis chamber did not permit the formation of nitrile hydrolysis products. Recently, 
molecular modeling of an Arabidopsis ESP sequence and two other specifier protein sequences 
(Lepidium sativum thiocyanate-forming protein (LsTFP) and Thlaspi arvense thiocyanate-
forming protein (TaTFP)), along with site-directed mutational analysis, was used by Brandt et al. 
(2014) to generate proposed docking site and reaction mechanisms for the specifiers with 
different glucosinolate aglycones. For all three specifier proteins, a conserved Fe
2+ 
binding 
domain was identified in the active site as well as a residue responsible for recognition of the 
aglycone sulfate group (R94). Interestingly, differences in the three active site conformations 
resulted in profound differences in allyl- and benzyl glucosinolate aglycone docking models that 
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corresponded to the differences among the specifier proteins in substrate and product 
specificities. This work provides theoretical support for the role of Fe(II) and ESP in catalyzing 
nitrile formation. 
  EMS1 was initially identified in Arabidopsis as a QTL that epistatically interacted with 
ESP to increase the formation of ITCs at the expense of nitrile formation (Lambrix et al. 2001). 
Zhang et al. (2006) successfully fine-mapped and cloned the causative gene of ESM1, which 
they identified as At3g14210 – an annotated MyAP. In vitro and in planta overexpression and 
knockout mutant combinations of ESP/ESM1 showed that ESM1 significantly increased ITC 
accumulation for aliphatic and aromatic GS hydrolysis regardless of the presence of ESP. This 
suggests that ESM1 either directly represses nitrile formation or stimulates ITC formation, but a 
distinction between these activities could not be made in this experiment. 
The influence of ESP and ESM1 on the ratio of ITC to nitrile formation upon GS 
hydrolysis makes them important targets for improving the chemopreventive bioactivity of 
Brassica vegetables. Breeding for decreased ESP and/or increased ESM1 activity is a likely 
approach for enhancing the conversion of GSs to ITCs. Manipulation of GS accumulation and 
hydrolysis in broccoli has been achieved by the exogenous application of MeJA (Ku et al. 2013). 
The application of MeJA four days prior to harvest elicited an increase in myrosinase and ESM1 
transcription relative to the control, which was positively associated with increased sulforaphane 
production in treated plants. This work demonstrates that cultural practices can serve as a 
strategy for producing functional foods in addition to traditional breeding methods.   
1.2.3 Health-promoting Activities of GS Hydrolysis Products 
 Cruciferous vegetable consumption has been associated with a reduction in risk for a 
number of diseases in epidemiological studies (Higdon et al. 2007); much of the health-
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promotion associated with Brassica vegetables has been attributed to glucosinolate hydrolysis 
product (GSHP) activity (Jeffery and Araya 2009). A recent review by Elbarbry and Elrody 
(2011) detailed the reported health effects of sulforaphane, the predominant ITC in broccoli, and 
the mechanisms by which it was able to protect cells. Cancer, diabetes, neurodegenerative 
diseases, cardiovascular disorders, kidney diseases, gastrointestinal disorders, and ocular 
diseases have all been reported to respond to sulforaphane treatment. One mechanism of 
chemoprevention is the down-regulation of cytochrome P450 enzymes that can activate pro-
carcinogens. Skupinska et al. (2009) demonstrated that sulforaphane and its analog alyssin 
inhibited CYP1A1 and CYP1A2 activity. A great deal of evidence has been generated in support 
of several other mechanisms of action for sulforaphane, namely, anti-inflammation, cell-cycle 
arrest, and apoptosis in pre-malignant and malignant tissues (Chen et al. 1998; Elbarbry and 
Elrody 2011). Nuclear factor κB (NF-κB) is an important pro-inflammatory and apoptosis-
blocking transcription factor that has been shown to play a critical role in cancer proliferation 
and metastasis (Baldwin 2001). Heiss et al. (2001) revealed that sulforaphane treatment of Raw 
macrophage cells inhibited NF-κB binding to DNA, likely due to increased glutathione 
concentration as NF-κB is tightly regulated by the cellular redox state.        
The pathway best characterized as a site of action for GSHPs is the Nrf2/Keap1/ARE 
signaling cascade. This is a pathway found in mammalian cells that up-regulates cytoprotective 
genes such as phase II detoxification enzymes (e.g. NADPH:quinone reductase (QR) and 
glutathione-S-transferase (GST)) in response to oxidant or electrophile exposure (Osburn and 
Kensler 2008). Nrf2 (nuclear factor erythroid 2-related factor 2) is a transcription factor that, 
when complexed with Maf (masculoaponeurotic fibrosarcoma) proteins, binds to the antioxidant 
response element/electrophile response element (ARE/EpRE) region in the promoter of its target 
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genes and activates transcription. Under basal conditions, Nrf2 is bound by a Keap1 (Kelch ECH 
associating protein 1) dimer in the cytoplasm and targeted for proteasomal degradation via the 
Cul3-based E3-ubiquitin ligase complex associated with Keap1 (Kansanen et al. 2013). Keap1 
has 27 cysteine residues that can be attacked by oxidants and electrophiles, including ITCs; 
changes to the cysteine thiol groups are believed to cause conformational changes in Keap1 that 
prevent Nrf2 ubiquitination. Under these circumstances Keap1 becomes saturated with Nrf2 that 
is not degraded, allowing newly synthesized Nrf2 to translocate to the nucleus and activate ARE-
controlled genes (Jaramillio and Zhang 2013). For a graphic depiction of Keap1 regulation of 
Nrf2 see Figure 1.4. A second important factor involved in Nrf2 activation is its phosphorylation 
by protein kinases. Rosaria et al. (2011) demonstrated that induction of phase II metabolism 
genes (glutathione, peroxidase, and glutathione reductase) in response to procatechuic acid 
treatment required the phosphorylation of Nrf2 by C-JUN NH2 terminal kinase (JNK). 
The importance of Nrf2 function in preventing carcinogenesis has been demonstrated in a 
number of studies testing the outcome of wild type and Nrf2 knockout mice after exposure to a 
variety of toxicants (Aoki et al. 2001; Ramos-Gomez et al. 2001; Iida et al. 2004; Osburn et al. 
2007). Nrf2 activation has also been demonstrated to play a role in anti-inflammation and 
mitigation of cardiovascular, kidney, respiratory, and ocular diseases (Elbarbry and Elrody 
2011). However, constitutive Nrf2 expression in tumor cells promotes resistances to 
chemotherapy drugs and radiotherapy due to the same phase II detoxification enzymes that clear 
carcinogens in healthy cells (Kansanen et al. 2013). Constitutive Nrf2 expression was also shown 
to promote cancer cell proliferation in coordination with the PI3K-Akt proliferative signaling 
pathway by promoting purine nucleotide synthesis and glutamine metabolism—important 
material and energy resources for cell growth and division (Mitsuishi et al. 2012). The dual role 
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of Nrf2 signaling in cancer prevention and promotion highlights the need to tailor cellular-
signaling modulation appropriately for the situation in order to achieve therapeutic effects. For 
example, broccoli cultivars with enhanced ITC production would be beneficial as a dietary 
component for cancer prevention, but would not be appropriate for chemotherapy patients unless 
a PI3K inhibitor was also administered.   
1.3 Phenolic Compounds 
 In addition to the glucosinolates, Brassica vegetables are also an important source of 
phenolic compounds in the diet. The protective effect of dietary antioxidants such as phenolic 
compounds was believed to stem from their ability to scavenge free radicals, inhibit chain 
initiation, and break chain propagation (Podsędek 2007). However, emerging research in the 
bioavailability and in vivo activity of polyphenols suggests that action upon intracellular 
signaling cascades involved in growth, proliferation, apoptosis, inflammation, metastasis, etc. 
may be a more likely mechanism of activity (Crozier et al. 2009). The primary antioxidants in 
vegetables are vitamins C and E, carotenoids, and phenolic compounds. The water-soluble 
antioxidants vitamin C and phenolics have been reported to contribute 80-95% of the total 
antioxidant capacity in broccoli (Podsędek 2007). Studies of the phenolic profile of broccoli 
florets have shown that the primary phenolic compounds present are flavonol and 
hydroxycinnamic acid derivatives, with the most significant flavonol constituents of broccoli 
being quercetin and kaempferol (Price et al. 1997; Price et al. 1998; Heimler et al. 2006). Table 
1.2 contains a list of hydroxycinnamic acids and flavonols in broccoli florets. 
Phenolic compounds constitute the largest and most ubiquitous category of secondary 
metabolites across the plant kingdom, displaying a breadth of structural and functional diversity. 
Phenolics are characterized as having at least one aromatic ring with at least one hydroxyl group 
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attached. For a table of general phenolic compound classifications and skeletons, see Table 1.3. 
Scaffolds ranging from monomeric compounds with a single phenol ring to conjugated 
polyphenols like condensed tannins constitute a greatly divergent biochemical pathway. Further 
modifications such as glycosylation and acylation result in tens of thousands of unique phenolic 
metabolites. The physiological roles for phenolic compounds are as diverse as their structures, 
including pigmentation, UV-light absorption, structural support, and defense against pathogens 
and herbivores (Cheynier et al. 2013). Due to their importance for plant performance and as 
bioactive phytochemicals, a substantial body of research has accumulated regarding plant 
phenolic biosynthesis and the regulation thereof.  
1.3.1 Phenylpropanoid Biosynthesis 
 Phenolic compound biosynthesis originates from the aromatic amino acids produced by 
the shikimate pathway. In the first committed step of the phenylpropanoid pathway, 
phenylalanine ammonia-lyase (PAL) catalyzes the conversion of phenylalanine to trans-
cinnamic acid, with the loss of ammonia. Trans-cinnamic acid is then hydroxylated at the C-4 
position by cinnamic acid 4-hydroxylase (C4H) [a cytochrome P450] to form p-coumaric acid. In 
order for further conversions to occur, at this point p-coumaric acid must be activated with the 
addition of malonyl-CoA by 4-coumaric acid:CoA ligase (4CL). In addition to the influence of 
4CL, the available pool of malonyl-CoA also plays a role in determining flux through this step in 
the pathway, as well as further steps in the flavonoid branch of phenylpropaniod biosynthesis. 
Malonyl-CoA is produced by the carboxylation of acetyl-CoA. This reaction is catalyzed by 
acetyl-CoA carboxylase (ACC), which must be biotinylated by holocarboxylase synthase 1 
(HCS1) in order to be active (Saito 2013).  
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From p-coumaroly-CoA, the phenylpropaniod pathway branches into a number of 
compound families. The flavonoid branch is entered via the condensation of p-coumaryol-CoA 
with three molecules of malonyl-CoA by chalcone synthase (CHS). Stepwise along the central 
flavonoid pathway, the enzymes chalcone-flavone isomerase (CHI), flavanone-3-hydroxylase 
(F3H), flavanol synthase (FLS), flavonoid-3’-hydroxylase (F3’H), dihydroflanol reductase 
(DFR), and leucoanthocyanidin dioxygenase/anthocyanidin synthase (LDOX/ANS) mediate the 
conversion between flavones, flavanols, and anthocyanins. The central phenylpropanoid pathway 
is presented in Figure 1.5. Beyond the central pathway, the final physiochemical properties of the 
phenolic compounds are determined by tailoring reactions that add glucosyl, acyl, and methyl 
moieties (Saito 2013). 
 Phenylpropanoid biosynthesis is controlled by overlapping regulatory signaling networks 
involved both in developmental processes and responses to the environment. The modulation of 
polyphenol biosynthesis has been shown to occur primarily through changes in transcription of 
the biosynthesis genes through the activation of transcription factors (TFs). The mechanism of 
transcriptional regulation for anthocyanin biosynthesis is the best-characterized system in the 
phenylpropaniod pathway (Cheynier et al. 2013).  
Anthocyanin biosynthesis genes are primarily controlled by MBW complexes, which are 
comprised of an R2R3MYB and a basic helix-loop-helix (bHLH) TF with a WDR (tryptophan-
aspartic acid dipeptide-repeat) protein. Different combinations of R2R3MYB and bHLH TFs 
provide specificity for the various gene families, while the WDR is conserved across all of the 
MBWs. MBWs may act as either activators or repressors of transcription. For example, in A. 
thaliana, MYB4 has been shown to actively repress sinapate ester biosynthesis in a UV-
dependent manner. Further complexity exists, however, as interactions between MBW 
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complexes and the control of MBW activity by ubiquitin-mediated protein degradation and 
microRNA have been identified. Transcription factors have been proven to be effective 
transgenes for controlling phenolic biosynthesis, although successful combinations of MYB and 
bHLH targets vary substantially by species (Cheynier et al. 2013) and over-expression of TFs 
can result in their regulation of genes outside of their usual target. For instance, over-expression 
of AtMYB12 has been shown to up-regulate the biosynthesis of caffeoylquinic acids and 
flavanols in tomato (Luo et al. 2008).  
1.3.2 Phenolic Compound Quantification 
 In the interest of improving the health benefits of broccoli consumption, the 
quantification of phenolic compounds (or antioxidant capacity as a proxy for phenolic content) 
and the elucidation of the genetic controls involved in their accumulation is desirable. One 
classic method of analyzing the total phenolic content is with the Folin-Ciocalteu reagent (FCR). 
Solvent extraction of broccoli samples with water, water and methanol, ethanol, and other 
solvents have been employed for use in determination of total phenolic content by FCR (Ares et 
al. 2013). FCR is a bright yellow reagent, which contains a tungsate-molybdate, that when 
reduced produces a blue species. The production of this species is measured by 
spectrophotometry, with the results analyzed against a dilution series of a standard compound 
such as gallic acid. Phenolic compounds only react with FCR under basic conditions, achieved 
by adjustment with sodium carbonate. At assay conditions, the phenolate anion reduces 
molybdenum by electron transfer. This reaction is not specific only to phenols, as other reducing 
agents such as vitamin C will react with FCR. Even so, its simplicity and reproducibility have led 
to the extensive use of FCR in the analysis of phenolic antioxidants (Huang et al. 2005).  
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 One method that has been utilized to evaluate the antioxidant capacity of broccoli 
samples is an assay involving a 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) 
radical (Ares et al. 2013). This radical is generated by the treatment of 7 mM ABTS (aqueous) 
with 2.45 mM potassium persulfate. The mixture is allowed to stand for 12-16 hours for the full 
color development (dark blue-green). Upon reduction of the radical, the original colorless state is 
restored. The change in absorbance of the reaction mixture with the antioxidant is measured by 
spectrophotometry after a six-minute incubation. The results are reported as equivalents of the 
change in absorbance elicited by 1 mM Trolox. Thus, this assay is often referred to as the Trolox 
equivalent antioxidant capacity (TEAC) assay (Huang et al. 2005). 
 Another commonly employed assay of antioxidant capacity is the 2,2-Diphenyl-1-
picrylhydrazyl (DPPH) radical scavenging assay (Ares et al. 2013). DPPH is a commercially 
available organic nitrogen radical that has a maximum absorption at 490 nm. In solution, DPPH 
appears dark purple; upon reduction, the color of the solution fades in proportion with the 
antioxidant concentration. The preferred solvent for DPPH is methanol, giving this assay not 
only a different radical species, but also a different solvent system from the ABTS assay. Though 
it is technically simple, there are limitations to the DPPH assay. It has been reported that the 
reaction of eugenol with DPPH was reversible. In this case, the reported antioxidant capacity of 
eugenol and potentially other phenolics with similar structures would be underestimated by the 
assay. This assay is also sensitive to pH changes in the solvent, which can alter the ionization 
equilibrium of the phenols and therefore change the reaction kinetics (Huang et al. 2005).  
1.3.3 Phenolic Compound-mediated Health Promotion 
 Interest in examining the health benefits of phenolic compounds began largely due to 
epidemiological evidence that diets rich in flavonoids and other phenolic compounds were 
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associated with lower risk of coronary heart disease (Hertog et al. 1995), breast (Sun et al. 2006), 
lung (Tang et al. 2009; Knekt et al. 2002), and prostate cancer, type II diabetes, and asthma  
(Knekt et al. 2002). However, other studies have shown inconsistent or no correlation between 
flavonoid intake and reduction in stomach and colorectal cancer (Woo and Kim 2013). The role 
of reactive oxygen species (ROS) in chronic disease (Ma 2014) and the strong ability of phenolic 
compounds to scavenge free radical in vitro led to the belief that this was a primary cause for the 
health benefits associated with their consumption (Masella et al. 2005). However, further 
investigation of the metabolism and disposition of phenolic compounds in humans revealed 
modest to low absorption and extensive conjugation and breakdown of phenolic metabolites 
(Clifford 2004; Bergman et al. 2010). Thus, the concentration of polyphenols in the plasma and 
tissues is much lower than the native radical scavenging molecules ascorbic acid and α-
tocopherol, making direct radical scavenging an unlikely mode of action for dietary phenolics. 
Instead, interaction with cellular signaling cascades is much more plausible (Crozier et al. 2009). 
There is evidence that supports a role for phenolic compounds in interactions with a number of 
different signaling molecules, including NF-κB, cyclooxygenase-2, caspases, Nrf2, and MAP 
kinase cascades (Chen et al. 2000; Kim et al. 2015; Weng et al. 2011).  
 Although direct radical scavenging is not a likely mechanism of cytoprotection in vivo, 
the reactivity of phenolic compounds with free radicals is not irrelevant. The same structural 
features that most commonly contribute to in vitro radical scavenging activity—ortho- and para-
hyroquinone moieties—also react readily with Keap1 cysteine thiolates. Other polyphenols that 
initially lack an electrophilic α,β-unsaturated carbonyl can be oxidized by free radicals to 
generate a quinone capable of reacting with Keap1. This elegantly illustrates how it is possible 
for “antioxidant” and “prooxidant” phenolic compounds and metabolites to positively impact the 
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cellular redox state—by inducing phase II detoxification genes through the Nrf2/ARE signaling 
pathway (Dinkova-Kostova et al. 2001; Forman et al. 2014).  
In addition to interacting at Keap1, polyphenols have also been demonstrated to induce 
MAP kinase activity involved in Nrf2 stabilization, nuclear translocation, and DNA binding 
(Varì et al. 2011). Weng et al. (2011) showed that quercetin treatment of human hepatoma 
HepG2 cells induced Nrf2 phosphorylation by JNK, ERK, p38, and Akt and promoted greater 
nuclear translocation and DNA binding. This study also found a significant correlation between 
the in vitro antioxidant activity of several polyphenols and their ability to promote phase II 
















1.4 Figures and Tables 
Figure 1.1 General glucosinolate structure with two specific examples of the variable R group: 
allylglucosinolate (sinigrin) and benzyl glucosinolate (glucotropaeolin)  







Figure 1.2 The glucosinolate biosynthesis pathway in Arabidopsis (Sønderby et al. 2010)
 
Figure 1.2 (a) side-chain elongation (b) core glucosinolate formation (c) secondary modifications 
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Figure 1.5 A generalized phenylpropanoid biosynthesis pathway (Saito et al. 2013)
 
Figure 1.5 PAL, phenylalanine ammonia-lyase; C4H, cinnamic acid 4-hydroxylase; 4CL, 4-coumaric acid: CoA ligase; ACC, acetyl-CoA 
carboxylase; CHS, chalcone synthase; CHI, chalcone isomerase F3H, flavanone 3-hydroxylase; F3′H, flavonoid 3′-hydroxylase; FLS, 

















Table 1.2a  Hydroxycinnamic acids in broccoli floret tissue (modified from Vallejo et al. 2003) 






    Neochlorogenic acid C1 4.2 332, 295sh 353, 179 
Chlorogenic acid C2 7.2 332, 295sh 353, 179 
Sinapic acid derivatives 
    1,2-Disinapoylgentiobiose 1 22.8 328 753, 529, 223 
1-Sinapoyl-2-feruloylgentiobiose 2 23.8 328, 295sh 723, 499, 223 
1,2,2′-Trisinapoylgentiobiose* 4 25.1 328 959, 735 
1,2′-Disinapoyl-2-feruloylgentiobiose 5 25.6 328, 295sh 929, 705 
1-Sinapoyl-2,2′-diferuloylgentiobiose 6 26.5 320, 290sh 899, 705 
1,2,2′-Trisinapoylgentiobiose* 7 27.6 328 959, 735 
Feruloyl acid derivatives 
    1,2-Diferuloylgentiobiose 3 24.3 328, 290sh 693, 499, 175 
* Isomeric compound; Rt, retention time; sh, spectrum shoulder   
 
Table 1.2b Flavonols in broccoli floret tissue (Price et al. 1997)
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Chapter 2. Gas chromatography-based Myrosinase Activity and QTL Mapping in Broccoli 
(Brassica oleracea L. var. italica) 
2.1 Abstract 
Quantitative trait loci (QTL) analysis of glucosinolate (GS) hydrolysis product formation 
and percent nitrile formation was conducted in a broccoli mapping population (B. oleracea) 
saturated with single nucleotide polymorphism markers from an Illumina 60K array designed for 
rapeseed (B. napus). In two years of analysis in North Carolina and one year in Illinois, variation 
in exogenous sinigrin and benzyl glucosinolate hydrolysis was associated with 52 QTL. 20 of 
these loci were identified in at least two analyses; the three most stable QTL (GSHP28, GSHP34, 
and GSHP48) were identified in five analyses. Genome-specific SNP markers were used to 
identify candidate genes within the QTL marker intervals. Genes involved glucosinolate 
biosynthesis and metabolism, including MYB transcription factors were identified as putative 
candidate genes. Most notably, CYP79, the first enzyme involved in the core GS biosynthesis 
pathway, was a putative candidate for 6 QTL, including GSHP28. The results demonstrate the 
complexity of the regulatory network involved in glucosinolate metabolism, but highlight 
potential targets for further investigation and the development of Brassica vegetables with 
enhanced GS hydrolysis product profiles. 
2.2 Introduction 
Over the last three decades, interest in the anticarcinogenic and health-promoting 
properties of fruit and vegetable compounds has spurred the development of a substantial body 
of research in this field. Vegetables in the Brassica genus, e.g. broccoli, cauliflower, cabbage and 
kale, are the primary source of glucosinolate hydrolysis products in the human diet. These 
compounds have been demonstrated—among other things—to induce detoxification enzymes, 
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mitigate inflammation, and decrease cancer risk (Zhang et al. 1992; Elbarbry and Elrody 2011; 
Verhoeven et al. 1996; Herr and Buchler 2010). 
Glucosinolates (GSs) are secondary plant metabolites with a core β-thioglucoside-N-
hydroxysulfate structure synthesized from amino acids (Travers-Martin et al. 2008). The most 
recent critical review of identified glucosinolate compounds presents 200 verified structures and 
an additional 180 theoretical structures extrapolated from known GSs (Clarke 2010). Within the 
Brassica genus, approximately 30 different glucosinolates are reported (Bellostas et al. 2007). 
A given glucosinolate can be placed into one of three categories based upon the amino 
acid it is derived from. Indole GSs are derived from tryptophan, aromatic GSs from 
phenylalanine or tyrosine, and aliphatic GSs from alanine, leucine, isoleucine, valine or 
methionine (Halkier and Gershenzon 2006). For a list of the GSs found in B. oleracea see Table 
2.1. The regulation and biosynthesis of GSs have been well studied in the related model plant 
Arabidopsis and a number of excellent reviews are available (Halkier and Gershenzon 2006; Yan 
and Chen 2007; Gigolashvili et al. 2009; Sønderby et al. 2010). A diagram of the GS 
biosynthesis pathway is included in Figure 2.11. 
Following biosynthesis, glucosinolates are stable and not biologically active until they are 
hydrolyzed by a myrosinase [β-thioglucosidase glucohydrolase (EC 3.2.1.147)]. Myrosinases are 
hydrolytic enzymes that cleave the thioglucoside bond, releasing glucose and forming an 
unstable aglycone thiohydroximate-O-sulfonate (Travers-Martin et al., 2008). The hydrolysis of 
GSs in healthy plant tissue occurs at a basal level due to the separate compartmentalization of 
glucosinolates and myrosinases (Kissen et al. 2009). Upon wounding or cellular disruption, GSs 
and myrosinases are brought into contact, allowing for a burst of glucosinolate hydrolysis.  
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The resulting aglycone then undergoes rearrangement and hydrogen sulfate release, 
which may result in a variety of products depending upon the pH (Gil and MacLeod 1980), 
ferrous ion concentration (Uda et al. 1986), the presence of specifier proteins [e.g. 
epithiospecifier protein (ESP) and epithiospecifier modifier (ESM1)] (Wittstock and Burow 
2007), and the structure of the aglycone (Yan and Chen 2007). Under neutral pH the primary 
products are isothiocyanates (ITCs), while in acidic conditions nitriles predominate. ESP 
functions in an Fe(II) dependent manner to promote the formation of epithionitrile (or nitrile) 
hydrolysis products (Tookey 1973; MacLeod and Rossiter 1985; Lambrix et al. 2001; Zabala et 
al. 2005; Matusheski et al. 2006; Williams et al. 2010), while ESM1 promotes the formation of 
isothiocyanates (Zhang et al. 2006). Other possible degradation products include thiocyanates 
resulting from the hydrolysis of indolic and aromatic glucosinolates, and oxazolidine-2-thiones 
from hydroxylated glucosinolates (Chen and Andreasson 2001). For a diagram of glucosinolate 
hydrolysis, see Figure 2.1.  
Ecologically, some of these hydrolysis products serve as defense compounds, exhibiting 
toxicity towards various plant pathogens and generalist herbivores (Bednarek et al. 2009; Fan et 
al. 2011; Barth and Jander 2006). Conversely, GS hydrolysis products serve as feeding 
attractants and oviposition cues for specialists such as the cabbage white moth, Pieris rapae 
(Wittstock et al. 2003). In mammalian systems, study of the chemopreventive bioactivity of GS 
hydrolysis products has demonstrated that ITCs are more potent anti-cancer agents than their 
respective nitriles (Nastruzzi et al. 2000). Crop improvement efforts necessarily must include 
enhancement in the conversion of GSs to ITCs. As human digestive enzymes and the gut 
microflora only hydrolyze a limited amount of GSs, the native plant myrosinases are responsible 
for producing the majority of ITCs available upon consumption (Conaway et al. 2000). Research 
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on the activity of myrosinase and the partitioning of hydrolysis products between nitrile and ITC 
forms is, therefore, a critical component that must be addressed in order to achieve the 
development of broccoli cultivars with improved in vivo anticarcinogenic activity.  
The objective of the present study was to utilize a B. oleracea L. var. italica (N = 9 CC) 
mapping population (VI-158 × BNC) to identify quantitative trait loci (QTL) associated with 
variability in myrosinase activity and hydrolysis product partitioning in broccoli florets. The 
parents of this population—VI-158, a calabrese-type double haploid of the F1 hybrid “Viking”, 
and “Broccolette Neri e Cespulgio” (BNC), a broccolette neri (black broccoli) accession (PI 
462209)—were selected for their contrasting glucosinolate profiles (Kushad et al. 1999; Brown 
et al. 2002) and crossed to produce an F2:3 mapping population (Brown et al. 2007). This 
population was recently saturated with single nucleotide polymorphism (SNP) markers from the 
Illumina 60K iSelect array designed for rapeseed (Brassica napus, N = 19 AACC) and anchored 
to the TO1000 B. oleracea reference sequence (Parkin et al. 2014) by genome-specific markers. 
This information was used to conduct QTL mapping of carotenoid and glucosinolate profiles and 
to identify putative candidate genes co-localizing with the QTL (Brown et al. 2014; Brown et al. 
2015). The present effort extends similar analysis to the qualitative and quantitative differences 
in the hydrolysis of two exogenous glucosinolates in the same population. 
2.3 Materials and Methods 
2.3.1 Cultivation of Plant Material  
 The biparental broccoli population used in this project was developed as described by 
Brown et al. (2007).  The parents were VI-158, a calabrese-type double haploid of the F1 hybrid 
“Viking” by a broccolette neri (black broccoli) accession “Broccolette Neri e Cespulgio” (BNC), 
PI 462209.  Freeze-dried samples of 92 F2:3 families grown in two field replications in 2009 and 
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2010 at North Carolina State University as described by Brown et al. (2014) were obtained from 
the Brown lab.   
 During the 2014 growing season, 115 F2:3 families from the VI-158 × BNC mapping 
population were grown at University of Illinois at Urbana-Champaign (UIUC).  Seeds were 
planted on May 28 in 48-cell flats filled with Sunshine® LC1 (Sun Gro Horticulture, Vancouver, 
British Columbia, Canada) professional potting mix.  Seedlings were germinated in the Plant 
Science Lab greenhouse under a14h/10h and 25°C/15°C day/night temperature regime for three 
weeks, and then were hardened off in an outdoor ground bed for two weeks prior to 
transplanting.  The plants were transplanted on July 7 to the University of Illinois South Farm 
(40° 04’ 38.89” N, 88° 14’ 26.18” W) and irrigated by hand during establishment.   
The field design consisted of a randomized complete block design with three replications. 
Guard rows were planted around the experimental plot to avoid border effects. Within each 
replicate, rows of ten plants spaced approximately 0.3m apart were included for each family, 
with 0.6m between rows.  Broccoli heads were harvested between August 3 and October 23, with 
at least five heads collected from each replicate of each family.  Heads were cut to similar size 
and stalk proportions, flash frozen immediately after harvest, and stored at -20°C.  The florets 
were lyophilized, ground to a fine powder with a coffee grinder, and stored at -20°C prior to 
analysis. Because the families were segregating for harvest date, multiple harvests were 
conducted to obtain heads at uniform maturity.  In instances where multiple harvests were 
required for a given replicate of a family, proportional dry weight per heads harvested on each 




2.3.2 Myrosinase Activity Measurement   
 Myrosinase activity of broccoli samples was determined by measuring the hydrolysis 
products formed from two exogenous GSs—sinigrin and benzyl glucosinolate, an aliphatic and 
an aromatic GS, respectively. In a 2 mL microcentrifuge tube (USA Scientific), 0.8 mL of the 
exogenous glucosinolate solution (1 mM sinigrin/ 1 mM benzyl glucosinolate/ 20 μgmL-1 butyl 
isothiocyanate (internal standard)) was added to 60 mg of lyophilized broccoli floret tissue and 
vortexed briefly. 30 sec later, 0.8 mL of hexane was added as the extraction solvent. The tube 
was vortexed for 4 sec and inverted for an additional 70 sec. Following inversion, the phases 
were separated by a 30-sec spin in a mini-centrifuge. At 2 min after hexane addition, the hexane 
layer was transferred to a 300 μL flat bottom insert (Fischer Scientific) in a 2 mL HPLC 
autosampler vial (Agilent, Santa Clara, CA, USA). 1 µL hexane extract was injected onto an 
Agilent 6890N gas chromatography system equipped with a single flame ionization detector 
(FID) (Agilent Technologies, Santa Clara, CA). Samples were separated using a 30 m x 0.32 mm 
J&W HP-5 capillary column (Agilent Technologies). The oven temperature program was as 
follows: hold 40°C 5 min/ ramp 10°Cmin-1 to 180°C/ ramp 30°Cmin-1 to 300°C/ hold 5 min. 
Injector temperature was 200 °C; detector temperature was 280 °C. Helium carrier gas flow rate 
was 25 mLmin-1. Standard compounds for allyl ITC (AITC), benzyl ITC (BITC), and benzyl 
cyaninde (BCN) were purchased from Sigma-Aldrich and standard curves were calculated in 
Excel (Microsoft Corp.) with the intercept set to zero. 1-cyano-2,3-epithiopropane (CETP) 
concentrations were based on the relative response factor calculated using the effective carbon 
number concept with respect to AITC and its standard curve (Scanlon and Willis 1985; Lambrix 
et al. 2001). Standard curves and the CETP relative response factor calculation are presented in 
Figure 2.6 and Equation 2.1. The simple nitrile hydrolysis product of sinigrin, allyl cyanide, was 
 39 
not measured due to interference with the solvent peak, and therefore, only the ESP-directed 
epithionitrile formation was quantified. The partitioning of the hydrolysis products between ITC 
and nitrile forms was calculated as the percentage the respective nitrile out of total hydrolysis 
product produced for a given glucosinolate. 
 When samples from 2014 were processed as stated above, the amount of hydrolysis 
products produced from benzyl glucosinolate (BZGS) was markedly lower than the amount 
produced by samples from 2009 and 2010, and the sinigrin (SN) hydrolysis products were 
undetected. Therefore, an altered protocol was developed for the 2014 population. 0.8 mL of 
exogenous GS solution was added to 60 mg of lyophilized broccoli floret tissue in a 2 mL 
microcentrifuge tube and incubated for 1 hr at room temperature. Following incubation, the 
samples were centrifuged for 5 min at 12,000 × g. Then, 0.8 mL of hexane was added to each 
tube and the samples were vortexed vigorously for two successive 30 sec intervals. The samples 
were centrifuged again for 5 min at 12,000 × g, and the hexane layer was transferred to a 250 µL 
spring-bottom insert in a 2 mL HPLC autosampler vial. The GC sample separation protocol was 
used as before. 
2.3.3 Statistical Analysis 
 Statistical analyses were conducted in the JMP 12 software package (SAS institute Inc., 
Cary, NC). ANOVA was conducted for all traits with all factors considered fixed (genotype, 
year, and replication). The general linear model was yijk =  µ + Gi  + Yj  + R(Y)jk  + εijk where y = 
the trait measurement associated with the individual ijk,  µ = overall population mean, G = 
genotype (family), Y = year (environment), R(Y) = replication (block) within year, and ε = 
experimental random error. The interaction between genotype and year was not fitted because 
there were insufficient degrees of freedom to estimate the effect. F-tests of effect significance 
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were obtained using the Standard Least Squares (SLS) method. Hydrolysis product formation 
and percent nitrile formation trait data was run in an ANOVA with all three years of data, but 
separate ANOVAs were conducted for the combined 2009 and 2010 data and the 2014 data as 
well due to the extreme difference in response of the population in 2014 and necessary 
differences in methodology. Pearson’s correlation coefficients of comparable trait combinations 
were generated using the Restricted Maximum Likelihood (REML) method.  
2.3.4 Identification of QTL 
 The linkage map used in this analysis was developed by Brown et al. (2014), with minor 
updates. It consists of 553 SNP markers from the Brassica napus (AACC) 60k Illumina iSelect 
array that are named according to the progenitor genome (“A” = B. rapa or “C” = B. oleracea) 
followed by the position of the SNP as referenced by the ‘Chiifu-401’ or ‘TO1000’ genome 
sequence, respectively. The map covers 433694475 bp of the 446,905,700-bp TO1000 reference 
assembly (97%. MapQTL
® 
5 (Van Ooijen 2004) was used to identify QTL associated with total 
hydrolysis product formation and the percent nitrile formation from individual glucosinolates 
(sinigrin and benzyl glucosinolate) and the combined totals in 2009, 2010, and 2014 when there 
was variability detected by ANOVA. Initially, non-parametric single-factor analysis was 
performed using the Kruskal-Wallis test to select a group of markers that were subsequently 
evaluated using the program’s default settings for automated backward-elimination cofactor 
selection.  The resulting model was tested by non-restricted multiple-QTL mapping (MQM) with 
the default settings adjusted to a scan distance of 0.5 cM. The process was iterated several times 
to produce an optimal set of cofactors. The genome-wide LOD-score threshold value for 
declaring the presence of a QTL (P < 0.05) was estimated by 1000 permutations of bootstrapping 
for each phenotypic trait. Confidence intervals were set using a 2-LOD drop off on either side of 
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the maximum score. A QTL was considered common between analyses if the confidence 
intervals overlapped and the direction of the QTL effect was the same.  
2.3.5 Candidate GS Metabolism Gene Analysis 
 Geneious® version 8.1 (Biomatters: http://www.geneious.com) NCBI Blastx (parameters 
set to megablast default) were used to conduct protein to nucleotide BLAST searches of the B. 
oleracea TO1000 reference genome for GS metabolism gene queries. The results of this search 
are presented in Table 2.10. For QTL that contained or were in close proximity to A-genome 
markers, the online Brassica napus database, BRAD (brassicadb.org), was used to search for 
potential gene candidates surrounding the marker using the website’s Gbrowse feature that 
searches gene annotations by chromosomal position. GS biosynthesis genes were previously 
identified by Brown et al. (2015) in the TO1000 reference genome, and the results of this work 
were presented in Table 2.11. Genes from this pool of a priori candidates that co-localized 
within or adjacent to a significant QTL interval were declared putative candidates genes 
contributing to the QTL effect. 
2.4 Results 
2.4.1 Phenotypic Analysis  
Myrosinase activity was determined by using gas chromatography to quantify the 
production of hydrolysis products from two exogenous GS, SN and BZGS, in three years of the 
broccoli mapping population VI-158 × BNC. The populations grown in North Carolina (2009 
and 2010) had measurable myrosinase activity after 2 min of hydrolysis, but the population 
grown in Illinois (2014) did not have detectable levels of AITC, CETP, or BCN after 2 min of 
hydrolysis. Therefore, a longer hydrolysis time (60 min) was used for 2014 samples to obtain 
quantifiable levels of hydrolysis products. The results of these measurements for the parental 
 42 
lines and the F2:3 families were reported in Table 2.2 Frequency distribution tables of the results 
were presented in Figures 2.2 and 2.3. Analysis of variance was conducted to identify traits with 
a significant genetic variance component. ANOVA tables and Pearson’s correlation coefficients 
(r) for all three years of data, 2009 and 2010 only, and 2014 data were presented in Table 2.3 – 
Table 2.8. BZGS hydrolysis did not have a significant genetic effect in 2009 and 2010 due to low 
variation for this trait, and percent nitrile formation of SN hydrolysis did not have a significant 
genetic effect in 2014 (very few families produced CETP in 2014). The distribution of BZGS 
and total HP percent nitrile formation in 2014 were skewed heavily to the right, so a natural log 
transformation was used to obtain normal distributions for ANOVA and QTL analysis of these 
traits. All traits were correlated in the combined three years of data and in the 2014 data. In 2009 
and 2010, the hydrolysis product formation traits were correlated with one another and the 
percent nitrile formation traits were correlated with one another. 
2.4.2 QTL Analysis  
 Quantitative trait loci analysis identified 52 loci at or above the genome-wide LOD 
threshold (3.7 – 4.5) associated with glucosinolate hydrolysis traits, which were designated 
GSHP01 – GSHP52. Table 2.9 presents the chromosomal positions, flanking SNP markers, LOD 
scores, allele effects, and a priori candidate genes for the QTL. An example of a LOD score plot 
is presented in Figure 2.4, illustrating the results of sinigrin hydrolysis product and percent nitrile 
formation from 2009. Candidate genes were declared if they co-localized within or adjacent to 
the QTL interval outlined by the flanking SNP markers. Of the 52 QTL, 19 did not have an a 
priori candidate identified within or adjacent to its significant interval. 
QTL were considered the same across multiple analyses if the significant marker 
intervals overlapped; 20 QTL were identified in at least two traits. The three most consistent 
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QTL (GSHP28, GSHP34, and GSHP48) were identified in five analyses. GSHP28 was located 
on chromosome 5 (C05) between markers Bn-C5-p07277640 and Bn-C5-p11983986. It 
explained up to 14.5% of the phenotypic variation in four hydrolysis product formation traits and 
percent nitrile formation trait. The allele effect functioned primarily in an additive manner, with 
parent VI-158 contributing the positive allele. Four candidate genes were identified within the 
significant GSHP28 interval, specifically CYP79, MAM/IPMS, MYB51, and SOT. GSHP34 was 
located on chromosome 6 (C06) between markers Bn-C6-p15107318 and Bn-C6-p15107318. It 
explained between 11.7% and 24.6% of the phenotypic variation for three hydrolysis product 
formation and two percent nitrile formation traits. The allele effect was predominantly additive, 
with VI-158 as the positive allele donor. Two putative candidate genes, PEN3 and GSTU20, 
were identified within the GSHP34 interval. Finally, GSHP48 was located on chromosome 9 
(C09) between Bn_A09_02730673 and Bn-C9-p05218392. It explained up to 23.1% of the 
phenotypic variation for 4 hydrolysis product formation traits in 2009 and the averaged 
2009/2010 data, and SN percent nitrile formation in 2010. The allele effect of this locus was 
additive in nature, and the positive allele was contributed by BNC. Two transcription factors, 
MYB28 and MYB34, were identified as candidate genes within GSHP48.  
Of the remaining QTL identified in multiple analyses, five were observed for three trait 
analyses and 12 occurred in two trait analyses. The candidate gene most frequently associated 
with QTL was CYP79, occurring in six different loci and 13 trait-years. MAM/IPMS was the 
second most common, identified in three QTL and 9 trait-years. The third most frequent gene 
candidate was MYB51, associated with 2 QTL and 8 trait-years. All three of the most frequent 
gene candidates were within the GSHP28 interval. The following gene candidates were ranked 
according to the number of trait-years (7, 6, 5, and 4 for the respective groupings) each was 
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identified in: SOT, PEN3 > MYB28 > MYB34, GSTU20 > CYP81, UGT74, GGP1, and FMOGS-
OX).   
2.5 Discussion 
 The use of gas chromatography to directly measure both isothiocyanate and nitrile or 
epithionitrile GS hydrolysis products affords a more detailed look at glucosinolate hydrolysis 
than is typically gathered through classic methods of myrosinase activity determination (e.g. pH-
stat and UV-spectrophotometry). As ITCs have been demonstrated to exhibit much greater 
potential health benefits than their respective nitrile forms, quantifying both the total production 
of GS hydrolysis products and the balance between ITCs and nitriles is important for enhancing 
the health-promotion potential of Brassica crops. Differences in hydrolysis outcomes for 
different classes of glucosinolates are also addressed in this work because both an aliphatic (SN) 
and an aromatic (BZGS) glucosinolate were used as substrates for hydrolysis.  
  The results of GS hydrolysis analysis in this study highlighted several interesting 
differences between substrates and years. BZGS hydrolysis product formation was consistently 
higher that SN hydrolysis product formation in all years of analysis. This may suggest 
preferential substrate specificity or greater catalytic activity of B. oleracea myrosinases toward 
BZGS vs SN in the VI-158 × BNC population. However, this result may be biased by the fact 
that the simple nitrile product of SN, allyl cyanide, was not detectable with the present GC 
method due to coelution with the solvent peak. In 2009 and 2010, there was insufficient variation 
in BZGS hydrolysis to detect any significant genetic effect, and therefore, no QTL analysis could 
be conducted.  
 The most surprising result from this analysis was the dramatic difference in the rate of 
hydrolysis product formation observed in the 2014 population as compared to the populations 
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grown in 2009 and 2010. It appears that geographic location and associated environmental 
factors such as temperature, water availability, photon flux, pest and disease pressure, etc. have a 
strong influence on myrosinase activity, as the response of the VI-158 × BNC population was 
vastly different between the North Carolina (2009 and 2010) and Illinois (2014) environments. 
The great number of interacting factors involved in this type of environmental effect poses 
several research questions regarding the response of myrosinase activity to environmental 
variables that could be investigated in future studies, likely beginning with controlled 
environment experimental designs.  
 Another somewhat unexpected result was the apparent lack of myrosinase gene homologs 
identified in the Blast searches of the TO1000 reference genome. When all six Arabidopsis 
myrosinase genes (TGG1 – TGG6) were used as BLAST queries, only one hit was identified in 
the entire TO1000 genome with reasonable query coverage (and not overwhelmingly convincing 
sequence identity) on C09. Myrosinase genes were also not included in the published TO1000 
annotations. One potential explanation for this result is that the myrosinase gene family 
underwent substantial rearrangement and/or divergent selection pressure after the genome 
triplication event that occurred following the diversification of the Arabidopsis and Brassica 
genus that led to substantial sequence variability among myrosinase gene homologs. Complex 
chromosomal rearrangements in the B. oleracea genome in contrast to the A. thaliana genome 
have been documented by Wang et al. (2011). 
  The identification of CYP79 as a candidate gene in one of the three most consistent QTL 
(GSHP28) and in five other QTL regions across the B. oleracea genome makes it the most well 
supported candidate gene. Notably, CYP79 is the enzyme responsible for the first step of the 
core glucosinolate biosynthesis pathway. This does, however, raise the question of how 
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biosynthetic genes could be involved in regulating GS catabolism. The author speculates that 
changes in flux through the GS biosynthesis pathway regulated by CYP79 and other biosynthesis 
genes may induce a downstream response that alters myrosinase or other GS hydrolysis-related 
gene expression. The number of biosynthetic genes identified as candidates under QTL suggests 
that the regulation of the entire glucosinolate defense system is highly coordinated, creating 
strong interactions between biosynthesis and catabolism. An additional hypothesis is that CYP79 
and some GS metabolism genes are both targets of a common regulator, so that a correlation may 
exist between CYP79 and another unknown target that is the actual causative gene in different 
GS metabolism phenotypes. 
 The candidate genes identified for GSHP48 are also interesting because of their known 
regulatory role in the GS biosynthesis pathway. MYB28 is the primary regulator of aliphatic GS 
biosynthesis, activating genes throughout the pathway. MYB34 is one of the primary regulators 
of indole GS biosynthesis, activating genes involved in synthesis of the precursor amino acid 
tryptophan as well as genes in the GS biosynthetic pathway. Stable association of these 
transcription factors with GS hydrolysis traits suggests that they may also target genes involved 
in GS metabolism or trans-activate other transcriptional regulators that influence hydrolysis.    
 A few of the gene candidates have known associations with glucosinolate hydrolysis. 
One of the putative candidates underlying the consistent QTL GSHP34 was PEN3. PEN3 is a 
known ABC transporter that has been demonstrated to play a role in the transport of GS 
hydrolysis products across the cell membrane. It is a critical component of the in vivo 
glucosinolate hydrolysis response to pathogenic attack (Lipka et al. 2008). While PEN3 itself is 
not likely to change the observed rate of hydrolysis product formation in our myrosinase activity 
measurements, coordinate regulation of PEN3 with myrosinase enzymes would clearly be 
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required for plant defense. Identifying known glucosinolate-metabolism loci as potential 
candidates for the QTL analysis supports the efficacy of the study. For QTL that lack a priori 
genes of interest, there is a great opportunity for further bioinformatics research to identify 
previously unknown regulators of glucosinolate hydrolysis.  
 Overall, this work has successfully characterized a more detailed picture of glucosinolate 
hydrolysis product profiles in a broccoli mapping population and has identified several targets 
for further investigation and potential use in marker-assisted selection for the improvement of 
Brassica cultivar hydrolysis product profiles. Increasing total hydrolysis and decreasing the 
proportion of nitrile: isothiocyanate products are both of importance in order for consumers to 















2.6 Figures and Tables 
Figure 2.1 Glucosinolate hydrolysis (Halkier and Gershenson 2006) 
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Figure 2.2 Distributions of sinigrin (SN) and benzyl glucosinolate (BZGS) hydrolysis product 
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Figure 2.3 Distributions of sinigrin (SN), benzyl glucosinolate (BZGS), and total hydrolysis 
product (Total HP) formation, percent nitrile formation, and the natural log transformation (Ln) 
of percent nitrile formation for benzyl glucosinolate and total hydrolysis products in 2014 
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Figure 2.4 An example of results from QTL mapping presented as a line plot of LOD-score vs. chromosomal position (cM) for 
sinigrin hydrolysis products (blue) and percent nitrile formation for sinigrin hydrolysis (red) in 2009 
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Table 2.2 Means, standard deviations, and ranges of glucosinolate hydrolysis product formation 
and percent nitrile formation in the florets of the parents and F2:3 families of the VI-158 × BNC 
broccoli population over three years of analysis  
Trait Parental line   F2:3 population 
  VI-158 BNC   Mean ± SD Range 
μmol SNa/g DW/min 
     2009 1.70 1.21 
 
1.78 ± 0.48 0.05 - 3.01 
2010 2.00 2.32 
 
1.95 ± 0.40 0.67 - 3.28 
2014 0.14 0.03 
 
0.06 ± 0.05 0.00 - 0.22 
μmol BZGSb/g DW/min 
     2009 4.24 4.19 
 
4.49 ± 0.44 0.62 - 5.93 
2010 4.24 4.38 
 
4.49 ± 0.22 3.82 - 5.66 
2014 0.16 0.11 
 
0.12 ± 0.03 0.03 - 0.19 
μmol TotHPc/g DW/min 
    2009 5.93 5.40 
 
6.24 ± 0.81 0.67 - 8.20 
2010 6.23 6.71 
 
6.44 ± 0.50 4.66 - 8.50 
2014 0.30 0.15  0.18 ± 0.08 0.03 - 0.41 
Percent Nitrile SN      
2009 9.71 0  7.62 ± 6.19 0 – 34.79 
2010 0 8.13  15.35 ± 7.99 0 – 38.53 
2014 0 0  0.18 ± 0.91 0 – 9.75 
Percent Nitrile BZGS      
2009 8.27 0.74  10.02 ± 5.94 0 – 32.30 
2010 1.62 6.69  13.16 ± 4.60 1.58 – 24.47 
2014 0.78 0.80  0.92 ± 1.07 0 – 10.22 
Percent Nitrile TotHP      
2009 8.70 0.58  9.37 ± 5.83 0 – 32.03 
2010 1.12 7.19  13.75 ± 5.09 1.11 – 26.69 
2014 0.40 0.62  0.68 ± 0.94 0 – 8.63 
a 
Sinigrin hydrolysis products 
b 
Benzyl glucosinolate hydrolysis products 
c 








Table 2.3 Analysis of variance of hydrolysis product formation of 2009, 2010, and 2014 data 
presented as sums of squares 
Source μmol SN/g DW/min μmol BZGS/g DW/min μmol TotHP/g DW/min 
Family 24.46** 6.97 42.11** 
Rep[Year] 3.18** 3.09** 11.85** 
Year 470.07** 2772.27** 5518.95** 
Error 54.81 41.28 139.58 
R2 0.92 0.99 0.98 
** significant at P < 0.01 
   






μmol SN/gDW/min 0.946** 0.974** 
μmol BZGS/gDW/min   0.995** 
** significant at P < 0.0001 
  
Table 2.5 Analysis of variance of hydrolysis product formation and percent nitrile formation of 
2009 and 2010 data presented as sums of squares 
Source 
μmol SN 
/g DW %N SN 
μmol 
BZGS/g DW %N BZGS 
μmol 
TotHP/g DW %N TotHP 
Family 154.82** 7911.12** 61.37 5723.57** 300.19** 4833.98** 
Rep[Year] 11.93** 245.18* 4.28* 5557.46* 28.92** 168.47* 
Year 2.17* 4598.55** 0.80 11281.02** 0.33 1434.76** 
Error  132.88 9357.24 119.46 5557.46 390.86 5877.45 
R2 0.57 0.59 0.35 0.51 0.46 0.53 
* and ** significant at P < 0.05 and P < 0.01 






Table 2.6 Pearson’s correlation coefficients (r) of hydrolysis product formation and percent 
nitrile formation in the 2009 and 2010 population data 
  %N SN 
μmol 





μmol SN/g DW 0.023 0.494** 0.053 0.899** 0.036 
%N SN 
 
0.057 0.788** 0.043 0.906** 
μmol BZGS/g DW 
  
0.166* 0.824** 0.133 
%N BZGS 
   
0.118 0.974** 
μmol TotHP/g DW      0.090 
* and ** significant at P < 0.01 and P < 0.001, respectively 
  
Table 2.7 Analysis of variance of hydrolysis product formation and percent nitrile formation in 
the 2014 population presented as sums of squares 
Source 
μmol SN/g 
DW %N SN 
μmol BZGS/g 
DW Ln[%N BZGS] 
μmol 
TotHP/g DW Ln[%N TotHP] 
Family 1613.8** 97.8 680.0** 114.3** 3930.5** 103.4** 
Rep 47.5** 0.3 3.8 3.6* 72.3* 2.4 
Error 976.1 156.4 496.4 78.8 2319.7 72.3 
R2 0.63 0.39 0.58 0.60 0.63 0.59 
* and ** significant at P < 0.01 and P < 0.001, respectively 
 
 
Table 2.8 Pearson’s correlation coefficients for hydrolysis product formation and percent nitrile 
formation in the 2014  
  %N SN 








μmol SN/g DW 0.306** 0.713** 0.953** 0.590** 0.425** 
%N SN 
 
0.155* 0.265** 0.473** 0.558** 
μmol BZGS/g DW 
 
0.891** 0.366** 0.254** 
μmol TotHP/g DW 
  
0.539** 0.384** 
Ln[%N BZGS]     0.971** 
* and ** significant at P < 0.001 and P < 0.0001, respectively 
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Table 2.9 QTL linkage map locations, flanking SNP markers, allele effects, phenotypic variation explained by the QTL, and candidate 
genes located within or adjacent to significant QTL intervals  
QTL Trait Chr. Pos. M1 M2 LOD μ_A μ_H μ_B %P Putative Candidates 
GSHP01 SN14 C01 1.626 Bn-C1-p00029741 Bn-C1-p00370644 5.22 4.91 2.62 3.27 18.4 CYP79 
  BZ14 C01 3.126 Bn-C1-p00029741 Bn-C1-p00370644 4.17 8.38 7.10 7.64 14.1 CYP79 
  TotHP14 C01 3.126 Bn-C1-p00029741 Bn-C1-p00370644 5.55 13.96 10.28 11.57 19.4 CYP79 
GSHP02 LnTot.N14 C01 5.941 Bn-C1-p00392363 Bn-C1-p00745287 6.3 -0.75 -1.19 -0.65 12.9 CYP79 
GSHP03 BZ.N910 C01 12.408 Bn-C1-p00745287 Bn-C1-p01703986 9.55 7.75 13.57 16.57 10.6 CYP81 
GSHP04 BZ.N910 C01 13.775 Bn-C1-p01789416 Bn_A01_01422384 13.37 17.83 11.69 6.48 16.6 Bra011611 (AT4G35380) 
  BZ09.N C01 15.424 Bn-C1-p01789416 Bn-C1-p02090899 3.8 14.38 13.85 10.48 8.9 Bra011611 (AT4G35380) 
  SN10 C01 15.424 Bn-C1-p01789416 Bn-C1-p02090899 3.81 3.73 4.04 4.25 7.4 Bra011611 (AT4G35380) 
GSHP05 BZ.N10 C01 28.937 Bn-C1-p03795271 Bn-C1-p04262558 9.54 7.63 3.99 3.22 17.9 Bra011232 (AT4G30920) 
GSHP06 BZ.N10 C02 0 Bn-C2-p00386520 Bn-C2-p00652259 5.04 5.82 7.63 5.04 8   
  SN910 C02 0.5 Bn-C2-p00386520 Bn-C2-p00652259 5.17 3.82 3.41 3.61 7.5   
  TotHP10 C02 1 Bn-C2-p00386520 Bn-C2-p00677863 4.19 13.24 12.65 12.64 11.6   
GSHP07 LnTot.N14 C02 3.131 Bn-C2-p00685796 Bn-C2-p01034829 5.99 -1.00 -0.39 -0.40 11.9 CYP79 
GSHP08 TotHP09 C02 12.983 Bn-C2-p01699405 Bn_A02_02557799 4.51 13.62 12.80 13.77 10.8 Bra02686 (AT5G07670) 
GSHP09 BZ.N910 C02 49.415 Bn-C2-p44087953 Bn-C2-p46217719 4.26 12.67 10.78 11.64 4.4 UGT74 
  SN.N10 C02 51.508 Bn-C2-p45299880 Bn-C2-p47374400 4.65 13.21 10.29 7.08 8.9 UGT74 
GSHP10 BZ09.N C02 56.47 Bn-C2-p48462140 Bn-C2-p48936754 4.2 12.64 9.26 12.22 10.1 
 GSHP11 SN10 C02 59.585 Bn-C2-p48936754 Bn-C2-p49156504 5.56 4.05 4.46 3.94 11.6   
  SN910 C02 59.585 Bn-C2-p48936754 Bn-C2-p48985239 5.59 3.72 4.08 3.67 7.5   
  SN.N910 C02 60.085 Bn-C2-p48936754 Bn-C2-p49156504 5.53 17.84 8.69 7.19 44.5   
GSHP12 LnTot.N14 C02 72.258 Bn-C2-p50724714 Bn-C2-p52210180 4.39 -0.91 -0.47 -0.50 8.5 MYB28 
GSHP13 BZ.N910 C03 8.905 Bn-C3-p01512237 Bn_A03_01990974 5.79 11.36 13.79 12.88 6.4 MYB29 
  BZ.N10 C03 9.389 Bn-C3-p01512237 Bn_A03_01990974 7.87 5.94 8.02 4.91 14.5 MYB29 
GSHP14 SN10 C03 35.826 Bn-C3-p06576558 Bn-C3-p08831790 4.67 3.71 3.98 4.27 8.4 
CYP81, NIT1, 
Bo3g021000, GSTF  
  BZ.N910 C03 37.326 Bn_A03_05866896 Bn-C3-p10393377 8.62 13.94 10.86 10.88 10.2 
CYP81, NIT1, 
Bo3g021000, GSTF  
GSHP15 SN910 C03 43.067 Bn-C3-p11334804 Bn-C3-p12420975 11.2 3.28 3.65 4.10 17.5 
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QTL Trait Chr. Pos. M1 M2 LOD μ_A μ_H μ_B %P Putative Candidates 
GSHP16 TotHP10 C03 48.762 Bn_A03_10081359 Bn-C3-p14150585 4.61 12.53 13.08 13.34 13.2 
 GSHP17 SN.N10 C03 78.919 Bn-C3-p27458727 Bn-C3-p28548059 6.37 13.38 13.30 6.91 12.8 BZO1, BCAT4 
GSHP18 BZ.N10 C03 87.92 Bn-C3-p32296708 Bn-C3-p33820188 6.23 5.34 7.95 5.53 9.6 
 
GSHP19 BZ.N910 C03 
125.73
5 Bn-C3-p63693019 Bn-C3-p64548416 8.24 10.40 11.72 13.53 9.2 ESM1 
GSHP20 LnBZ.N14 C04 16.377 Bn-C4-p02539802 Bn-C4-p03415373 3.8 -0.23 -0.29 -0.91 16.3 PEN2 
GSHP21 BZ.N10 C04 22.091 Bn-C4-p04002305 Bn-C4-p04833836 4.35 4.02 6.09 6.84 7.1   
  SN10 C04 23.591 Bn-C4-p04002305 Bn-C4-p04833836 7.67 4.42 4.13 3.44 17   
GSHP22 SN10 C04 43.103 Bn-C4-p11015238 Bn-C4-p31914306 6.32 3.53 3.92 4.46 13.5 
UGT74, ALK/OH, 
MAM/IPMS, SOT 
GSHP23 BZ09.N C04 76.709 Bn-C4-p50781360 Bn-C4-p51049021 4.18 10.65 10.47 14.21 10 CYP83 
  BZ.N910 C04 76.709 Bn-C4-p50781360 Bn-C4-p51049021 10.98 10.68 10.29 13.63 13 CYP83 
GSHP24 SN.N09 C05 2.808 Bn-C5-p00160625 Bn-C5-p00230524 3.86 10.61 5.54 8.04 18.5 
 GSHP25 BZ09.N C05 7.359 Bn-C5-p00899151 Bn-C5-p01278013 4.39 14.75 10.76 10.10 10.6 
 GSHP26 LnTot.N14 C05 15.626 Bn-C5-p01390820 Bn-C5-p01924097 4.59 -0.65 -0.28 -0.75 9.3 
 GSHP27 BZ09.N C05 41.985 Bn-C5-p05223886 Bn-C5-p07277640 5.15 9.87 11.97 14.99 12.8 FMO-GSOX, PEN3 
  BZ.N910 C05 41.985 Bn-C5-p05223886 Bn-C5-p07277640 5.87 10.81 10.00 13.50 6.2 FMO-GSOX, PEN3 
GSHP28 Tot910 C05 46.275 Bn-C5-p07277640 Bn-C5-p07650408 3.82 13.25 12.49 12.68 14.5 
CYP79, MAM/IPMS, 
MYB51, SOT 
  TotHP09 C05 46.333 Bn-C5-p07607063 Bn-C5-p09973851 4.1 13.97 12.99 13.56 9.5 
CYP79, MAM/IPMS, 
MYB51, SOT 
  SN910 C05 46.833 Bn-C5-p07277640 Bn-C5-p07650408 8.29 3.93 3.45 3.41 11.6 
CYP79, MAM/IPMS, 
MYB51, SOT 
  LnTot.N14 C05 46.833 Bn-C5-p07607063 Bn-C5-p09973851 4.28 -0.87 -1.01 -0.54 8.4 
CYP79, MAM/IPMS, 
MYB51, SOT 
  SN10 C05 48.738 Bn-C5-p07650408 Bn-C5-p11983986 5.1 4.17 3.63 3.82 9.5 
CYP79, MAM/IPMS, 
MYB51, SOT 
GSHP29 BZ.N910 C05 52.641 Bn-C5-p09973851 Bn-C5-p12049575 7.91 14.65 18.60 9.67 8.9 
 GSHP30 BZ.N910 C05 54.464 Bn-C5-p12049575 Bn-C5-p13086950 5.15 10.71 6.79 13.39 6.3 UGT74 
GSHP31 SN.N10 C06 29.352 Bn_A07_20230189 Bn-C6-p03455997 3.94 8.45 12.76 11.83 7.4 SOT 3 copies 
GSHP32 SN10 C06 33.185 Bn-C6-p03455997 Bn-C6-p04527557 5.46 3.69 4.09 4.34 11.7   
Table 2.9 (cont.) 
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QTL Trait Chr. Pos. M1 M2 LOD μ_A μ_H μ_B %P Putative Candidates 
  SN910 C06 33.685 Bn-C6-p03455997 Bn-C6-p04527557 4.77 3.49 3.84 3.96 7   
GSHP33 BZ.N10 C06 49.329 Bn-C6-p08336574 Bn-C6-p11780787 4.36 4.27 6.66 6.59 6.6 CYP81, SOT 
GSHP34 BZ.N910 C06 58.353 Bn-C6-p15107318 Bn-C6-p19506663 10.02 13.58 10.41 10.73 11.7 PEN3, GSTU20 
  SN14 C06 59.353 Bn-C6-p15107318 Bn-C6-p19506663 4.85 6.13 3.94 2.91 20.4 PEN3, GSTU20 
  TotHP14 C06 59.353 Bn-C6-p16439278 Bn-C6-p20200556 6.3 15.13 11.42 9.61 24.6 PEN3, GSTU20 
  BZ14 C06 60.539 Bn-C6-p16439278 Bn-C6-p20200556 6.46 9.13 7.50 6.91 22.8 PEN3, GSTU20 
  BZ09.N C06 62.603 Bn-C6-p17633267 Bn-C6-p31037793 6.36 14.43 9.91 10.43 16.1 PEN3, GSTU20 
GSHP35 BZ.N910 C07 63.443 Bn-C7-p43333164 Bn-C7-p44016812 10.91 13.34 14.46 10.98 13   
  BZ.N10 C07 63.943 Bn-C7-p43333164 Bn-C7-p44016812 10.91 7.20 8.53 3.37 22.3   
GSHP36 TotHP10 C07 77.05 Bn-C7-p45715611 Bn-C7-p45821943 3.96 12.52 12.88 13.30 11.4 
 GSHP37 SN.N10 C07 80.122 Bn-C7-p45821943 Bn-C7-p46299784 5.56 21.07 21.03 -0.79 11.5 GGP1 
  Tot.N910 C07 80.122 Bn-C7-p45821943 Bn-C7-p46299784 5.38 17.70 17.69 1.49 22 GGP1 
GSHP38 Tot.N910 C07 83.733 Bn-C7-p46744839 Bn-C7-p47012082 3.97 2.91 3.07 16.29 15.2 CYP79 
  SN.N10 C07 86.344 Bn-C7-p46744839 Bn-C7-p47012082 4.95 2.05 4.54 18.09 9.6 CYP79 
GSHP39 TotHP09 C08 1.538 Bn-C8-p11379456 Bn-C8-p14639728 4.59 13.07 14.08 14.32 11.1 
 
GSHP40 SN910 C08 11.6 Bn-C8-p20224356 Bn_A08_19541990 6.16 3.39 3.75 4.00 8.7 FMO-GSOX 
GSHP41 BZ.N10 C08 21.865 Bn-C8-p26535332 Bn-C8-p25697764 3.87 4.55 8.14 6.31 6.7 BCAT3 
GSHP42 BZ.N10 C08 29.468 Bn-C8-p30785808 Bn-C8-p31898562 6.83 4.76 1.50 6.10 12.7 
 GSHP43 LnTot.N14 C08 34.925 Bn-C8-p31898562 Bn-C8-p33381033 8.77 -0.48 -1.93 -0.93 19.2 Bra007675 (AT3G62360) 
GSHP44 TotHP09 C08 38.881 Bn-C8-p34301437 Bn-C8-p35839772 4.63 12.70 14.36 14.69 11.2 GGP1 
  LnTot.N14 C08 38.881 Bn-C8-p34301437 Bn-C8-p35839772 8.19 -0.82 0.47 -0.59 17.7 GGP1 
GSHP45 TotHP09 C08 44.947 Bn-C8-p36677731 Bn-C8-p37222943 7.04 14.74 12.58 12.65 18 MYB51, MAM/IPMS 
  SN910 C08 44.947 Bn-C8-p37211319 Bn-C8-p37400663 7.7 3.90 3.40 3.48 10.8 MYB51, MAM/IPMS 
  SN10 C08 48.203 Bn-C8-p37400663 Bn-C8-p37703534 5.88 4.11 3.55 3.88 11.7 MYB51, MAM/IPMS 
GSHP46 BZ.N10 C08 57.145 Bn-C8-p39140884 Bn-C8-p39998098 3.81 6.88 7.43 3.97 7.2 FMO-GSOX, Dof1.1 
GSHP47 TotHP10 C09 24.857 Bn-C9-p02919255 Bn-C9-p04130002 4.69 12.59 13.17 13.38 13.3 
 GSHP48 TotHP09 C09 30.471 Bn_A09_02730673 Bn-C9-p05218392 6.52 12.79 13.50 14.60 16.6 MYB34/28 
  SN.N10 C09 30.471 Bn_A09_02730673 Bn-C9-p05218392 3.9 13.31 6.92 6.98 7.6 MYB34/28 
  SN910 C09 30.471 Bn_A09_02730673 Bn-C9-p05218392 8.22 3.31 3.76 4.07 11.8 MYB34/28 
Table 2.9 (cont.) 
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QTL Trait Chr. Pos. M1 M2 LOD μ_A μ_H μ_B %P Putative Candidates 
  Tot910 C09 31.471 Bn_A09_02730673 Bn-C9-p05218392 3.79 12.42 12.96 13.50 14.9 MYB34/28 
  SN09 C09 33.471 Bn-C9-p04273944 Bn-C9-p06763573 4.72 2.91 3.61 4.18 23.1 MYB34/28 
GSHP49 SN.N10 C09 44.136 Bn-C9-p05218392 Bn-C9-p08945466 8.41 4.62 16.00 15.67 18.7 APK1 
GSHP50 SN.N10 C09 63.48 BN_A10_07186465 Bn-S_01250-p13914 4.8 12.60 6.89 7.69 9.5 
 GSHP51 LnTot.N14 C09 87.62 Bn-C9-p50630273 Bn-C9-p51326764 4.28 -0.56 -1.01 -0.85 8.2 
 GSHP52 SN910 C09 108.22 Bn-C9-p52788004 Bn-C9-p53208843 4.88 3.75 4.02 3.62 7 CYP79 
  BZ09.N C09 114.88 Bn-C9-p53208843 Bn-C9-p54245986 4.33 12.47 15.62 12.39 10.5 CYP79 
 
Chr., Chromosome number; Pos., most likely position for QTL on chromosome (cM); M1, Front flanking SNP marker; M2, Back 
flanking SNP marker; LOD, Logarithm of the odds; μ_A, mean for homozygous QTL marker allele from parent 1 (VI-158); μ_H, mean 
for heterozygous QTL marker allele; μ_B, mean for homozygous QTL marker allele from parent 2 (BNC); %P, percent of the 
phenotypic variation explained by the QTL (overestimated for linked QTL) 
Trait designations: SN09, sinigrin hydrolysis products in 2009; BZ10, benzyl glucosinolate hydrolysis products in 2010; SN.N09, 
percent nitrile formation of sinigrin hydrolysis products in 2009; SN910, sinigrin hydrolysis products averaged across 2009 and 2010; 
TotHP10, total hydrolysis product formation in 2010; LnTot.N14 the natural log transformation of percent nitrile formation of total 
hydrolysis products in 2014 
Table 2.9 (cont.) 
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2.7 Supplemental Figures and Tables 
Figure 2.5 The GS biosynthesis pathway in Arabidopsis (Sønderby et al. 2010)  
 
 
Fig 2.5 (a) side-chain elongation (b) core glucosinolate formation (c) secondary modifications 
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Figure 2.6 FID peak area vs analytical standard GSHP concentration (μgmL-1) 
 
Equation 2.1 Calculation of the relative response factor for CETP based upon the effective 
carbon number method (Scanlon and Willis 1985; Lambrix et al. 2001). 
 
F(R-wt): Relative weight response factor 
MW of comp: Molecular weight of the compound 
MW of ref: Molecular weight of the reference compound 
ECN-ref: Effective carbon number of the reference compound 
ECN-comp: Effective carbon number of the compound 
 
𝐹(𝑅 − 𝑤𝑡)𝐶𝐸𝑇𝑃 =  
𝑀𝑊 𝐶𝐸𝑇𝑃 ×  𝐸𝐶𝑁 𝐴𝐼𝑇𝐶
𝑀𝑊 𝐴𝐼𝑇𝐶 ×   𝐸𝐶𝑁 𝐶𝐸𝑇𝑃
 
 
99.2𝑔 𝑚𝑜𝑙⁄ ×  3.9
99.2𝑔 𝑚𝑜𝑙⁄ ×  3.3
= 1.18
y = 11.854x 
R² = 0.99941 
y = 19.986x 
R² = 0.99216 
y = 15.466x 
R² = 0.9886 
y = 8.737x 
























Table 2.10 Protein to nucleotide BLAST results of glucosinolate metabolism gene queries against the B. oleracea TO1000 reference 




Percent of query coverage; 
c 
Percent identity between query and Blast hit 
 









Bo1g123520 NSP1 1 36888289 36889242 0 67.66 84.3 AEE75808.1 
Bo1g123520 NSP2 1 36888289 36889236 0 67.09 87.3 AEC08781.1 
Bo2g013450 NIT1 2 4188402 4189004 9.94E-93 78.13 72.1 AEE77888.1 
Bo2g124420 ESP 2 38381070 38381858 4.04E-128 100 75 AEE33039.4 
Bo3g020990 NIT1 3 6945050 6945673 6.37E-95 78.13 71.2 AEE77888.1 
Bo3g021000 
putative Glucosidase 
II beta subunit%2C 
3 6951621 6955614 not a Blast search result (TO1000 annotation) 
Bo3g184380 ESM1 3 63872321 63873154 2.94E-111 63.01 65 NP_188037.1 
Bo5g125020 NSP1 5 38466889 38467923 1.96E-178 67.23 77.1 AEE75808.1 
Bo5g125020 NSP2 5 38466889 38467923 6.17E-171 67.09 75.1 AEC08781.1 
Bo5g126100 NSP1 5 38563583 38564662 1.89E-172 67.23 72.2 AEE75808.1 
Bo5g130540 ESM1 5 40472110 40473051 1.64E-121 64.54 63.1 NP_188037.1 
Bo6g032900 MVP1 6 8075424 8074465 4.26E-120 66.19 65.5 NP_175805.1 
Bo6g032960 ESP 6 8134649 8135437 2.11E-129 100 76.1 AEE33039.3 
Bo6g010880 PEN3 6 24140810 24145823 0 85 86 NM_122501.3 
Bo7g067500 ESP 7 26439876 26440664 8.51E-131 100 76.9 AEE33039.2 
Bo7g067530 ESP 7 26483688 26484476 8.51E-131 100 76.9 AEE33039.1 
Bo9g049870 TGG2 9 15462772 15464379 7.44E-128 89.21 41.2 AED93508.1 
Bo9g049870 TGG4 9 15462772 15464379 4.85E-128 94.72 43.4 AEE32191.1 
Bo9g049870 TGG5 9 15462772 15464379 1.66E-127 94.72 43.6 AEE32671.1 
Bo9g049870 TGG1 9 15462934 15464379 4.84E-101 94.96 38.4 NP_197972.2 
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Table 2.11 Bioinformatics outcome/results for protein to nucleotide blast searches of the B. olereacea TO1000 genome sequence 
(Brown et al. 2015). 
 
 




end Gene product/protein/enzyme E-value 
Chromosome 1           
CYP79 Bo1g002970 480,326 482,164 Cytochrome P450 0 
CYP81 Bo1g004740 951,852 954,339 Cytochrome P450 3.65E-133 
GGP1 Bo1g012070 4,388,641 4,390,085 GMP synthase [glutamine-hydrolyzing] subunit A%2C putative 5.98E-108 
SUR1 Bo1g017510 6,069,769 6,071,594 Aminotransferase family protein 3.67E-139 
SUR1 Bo1g017520 6,073,481 6,075,414  Aminotransferase family protein 1.52E-102 
ST5b Bo1g019410 6,771,451 6,772,337 Non-ltr retrotransposon reverse transcriptase-like protein 0 
BCAT3 Bo1g080200 23,745,655 23,748,427 Branched-chain-amino-acid aminotransferase 0.00E+00 
UGT74 Not in GFF 27,749,914 27,749,641 UDP-Glycosyltransferase superfamily protein 1.37E-82 
SOT Bo1g094390 27,853,598 27,857,245 Protein kinase superfamily protein 0 
Chromosome 2           
CYP79 Bo2g006900 1,115,528 1,118,093 Cytochrome P450 0 
IPMDH * 3,192,468 3,194,395 3-isopropylmalate dehydrogenase 0.00E+00 
GSTF Bo2g013490 4,206,280 4,209,081 Glutathione S-transferase 1.39E-104 
CYP81 Bo2g032590 9,331,130 9,332,892 Cytochrome P450 0 
BZO1 Bo2g052590 14,950,949 14,952,522 2-succinylbenzoate-CoA ligase 3.12E-141 
SOT Bo2g080910 22,658,138 22,659,151 Sulfotransferase 0 
IPMDH Bo2g095850 27,128,156 27,130,313 3-isopropylmalate dehydrogenase 5.87E-101 
MAM/IPMS Bo2g098780 27,939,383 27,940,878 2-isopropylmalate synthase 0 
MAM/IPMS Bo2g102060 29,516,863 29,523,241 2-isopropylmalate synthase 3.05E-126 
ALK/OH Bo2g102190 29,633,877 29,636,206 2-oxyglutarate-dependent dioxygenase 2.00E-64 
UGT74 * 45,901,979 45,902,243 UDP-Glycosyltransferase superfamily protein 3.67E-96 
MAM/IPMS Bo2g161090 50,470,745 50,471,857 2-isopropylmalate synthase 0.00E+00 
MYB34 Bo2g161170 50,563,060 50,567,283 MYB domain protein 34-2 0.00E+00 
MYB28 Bo2g161590 50,898,605 50,900,210 MYB domain protein 28-3 0 
CHY1 Bo2g167570 52,309,559 52,312,167 Fatty acid oxidation complex subunit alpha 5.08E-35 
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end Gene product/protein/enzyme E-value 
 
Chromosome 3 
          
MYB29 Bo3g004500 1,664,674 1,666,127 MYB domain protein 29-1 0 
ALK/OH Bo3g018040 5,961,505 5,962,801 
2-oxyglutarate (2OG) and Fe(II)-dependent oxygenase 
superfamily protein 
2.00E-93 
CYP81 Bo3g019420 6,625,672 6,627,975 Cytochrome P450 0 
GSTF Bo3g024840 9,355,353 9,356,248 Glutathione S-transferase 0 
GSTF Bo3g024850 9,358,112 9,359,312 Glutathione S-transferase 1.56E-152 
IMPMI Bo3g036360 14,343,580 14,344,317 3-isopropylmalate dehydratase%2C small subunit 8.81E-115 
BAT5 Bo3g045530 19,173,100 19,174,972 Bile acid:sodium symporter family protein 0 
GS-Alk Bo3g052110 20,369,203 20,371,613 2-oxyglutarate-dependent dioxygenase 3.93E-63 
IQD1-1 Bo3g061890 23,722,169 23,724,241 IQ domain-containing protein 0 
BZO1 Bo3g073020 28,085,020 28,087,169 2-succinylbenzoate-CoA ligase 0 
BCAT4 Bo3g073430 28,353,880 28,355,455 Branched-chain-amino-acid aminotransferase 5.54E-102 
CYP79 Bo3g152800 54,189,645 54,192,136 Cytochrome P450 0 
CYP81 Bo3g153480 54,761,324 54,763,665 Cytochrome P450 9.18E-122 
UGT74 * 60,374,066 60,374,331 UDP-Glycosyltransferase superfamily protein 8.07E-92 
GGP1 Bo3g175530 61,484,682 61,486,416  Class I glutamine amidotransferase-like superfamily protein 1.15E-115 
Chromosome 4           
IMPMI Bo4g018580 2,505,319 2,506,083 3-isopropylmalate dehydratase%2C small subunit 1.59E-92 
IMPMI Bo4g018590 2,507,013 2,507,789 3-isopropylmalate dehydratase%2C small subunit 0.00E+00 
UGT74 Bo4g049480 11,284,952 11,288,030 UDP-Glycosyltransferase superfamily protein 0 
ALK/OH Bo4g053900 12,437,144 12,439,344 
2-oxoglutarate (2OG) and Fe(II)-dependent oxygenase-like 
protein 
6.26E-59 
MAM/IPMS Bo4g106300 26,488,408 26,490,052 hypothetical protein 5.92E-168 
SOT Bo4g120620 31,543,329 31,546,325 Sulfotransferase 5b 0 
CYP83 Bo4g130780 33,688,726 33,690,348 





Bo4g131050 33,964,963 33,968,400 3-isopropylmalate dehydratase large subunit 0.00E+00 
Table 2.11 (cont.) 
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end Gene product/protein/enzyme E-value 
CYP79 Bo4g149550 40,451,072 40,453,297 Cytochrome P450 0 
CHY1 Bo4g169200 45,207,990 45,210,381 Fatty acid oxidation complex subunit alpha 1.46E-35 
ALK/OH Bo4g173530 46,160,304 46,161,560 
















GSTF Bo4g173610 46,248,704 46,249,582 Glutathione S-transferase 8.66E-99 
UGT74 Bo4g177540 46,925,776 46,927,452 UDP-Glycosyltransferase superfamily protein 0 
MAM/IPMS Bo4g183080 48,542,582 48,546,527 2-isopropylmalate synthase 1.79E-160 
CYP83 Bo4g191120 51,640,085 51,641,715 
cytochrome P450%2C family 83%2C subfamily A%2C 
polypeptide 
0 
Chromosome 5           
ALK/OH Bo5g007640 2,463,484 2,465,755 
2-oxyglutarate (2OG) and Fe(II)-dependent oxygenase 
superfamily protein 
2.00E-97 
Dof1.1 Bo5g008360 2,815,697 2,817,035 Dof zinc finger protein 0 
FMO-GSOX Bo5g017150 5,648,265 5,650,672 Flavin-containing monooxygenase family protein 2.63E-52 
CYP79 Bo5g021810 7,831,826 7,834,735 
cytochrome P450%2C family 79%2C subfamily F%2C 
polypeptide 
0.00E+00 
MAM/IPMS Bo5g025510 8,846,276 8,849,447 2-isopropylmalate synthase 1.00E-105 
MYB51 Bo5g025570 8,865,564 8,866,909 MYB domain protein 51-2 0 
SOT Bo5g025610 8,890,802 8,891,815 Sulfotransferase 5c 0 
UGT74 Bo5g041080 13,359,153 13,360,726 UDP-glycosyltransferase 74 F1 0 
UGT74 * 33,247,489 33,247,754 UDP-Glycosyltransferase superfamily protein 1.78E-87 
BCAT4 Bo5g113720 34,732,385 34,734,977 Branched-chain-amino-acid aminotransferase 8.79E-106 
GSTF Bo5g150180 46,211,648 46,212,493 Glutathione S-transferase 0 
Chromosome 6           
SOT Bo6g008450 2,913,771 2,914,787 Sulfotransferase 5a 0 
SOT Bo6g008460 2,918,946 2,919,980 Sulfotransferase 5b 0 
SOT Bo6g008470 2,929,875 2,930,909 Sulfotransferase 5b 0 
Table 2.11 (cont.) 
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end Gene product/protein/enzyme E-value 
BZO1 Bo6g027260 8,135,892 8,137,885 4-coumarate-coa ligase 0 
CYP81 Bo6g031790 10,328,212 10,329,227 Cytochrome P450 1.66E-118 
SOT Bo6g035400 11,495,211 11,496,170 Sulfotransferase 5b 0 
GSTU20 Bo6g045200 14,446,828 14,447,794 Glutathione S-transferase 1.39E-136 
Chromosome 7           
SUR1 Bo7g003330 310,954 312,993 Aminotransferase family protein 0 
MAM/IPMS Bo7g098000 38,240,972 38,243,771 2-isopropylmalate synthase 4.83E-130 
MYB34 Bo7g098110 38,315,744 38,317,696 MYB domain protein 34-2 0 
MYB28 Bo7g098590 38,581,171 38,582,546 Myb domain protein 0 
BAT5 Bo7g108280 42,549,931 42,551,722 Bile acid:sodium symporter family protein 1.22E-134 
GGP1 Bo7g114570 45,553,238 45,554,639 GMP synthase [glutamine-hydrolyzing] subunit A%2C putative 2.38E-100 
CYP79 Bo7g118840 47,771,851 47,774,163 Cytochrome P450 0 
Chromosome 8           
Dof1.1 Bo8g010700 1,684,443 1,686,061 Dof zinc finger protein 0 
CYP83 Bo8g024390 6,342,140 6,343,791 
cytochrome P450%2C family 83%2C subfamily B%2C 
polypeptide 
0 
FMO-GSOX Bo8g062610 20,210,330 20,212,245 Flavin-containing monooxygenase family protein 1.90E-108 
MYB51 Bo8g067910 22,081,783 22,083,316 MYB domain protein 51-2 0 
BCAT3 Bo8g078930 25,916,758 25,918,830 Branched-chain-amino-acid aminotransferase 0.00E+00 
GGP1 Bo8g100210 34,698,336 34,700,187 GMP synthase [glutamine-hydrolyzing] subunit A%2C putative 1.32E-65 
MYB51 Bo8g104300 36,560,146 36,561,398 MYB domain protein 51-1 0 
MAM/IPMS Bo8g104370 36,589,437 36,592,546 2-isopropylmalate synthase 1.00E-83 
FMO-GSOX Bo8g108390 38,638,483 38,640,277 Flavin-monooxygenase 3.92E-88 
Dof1.1 Bo8g112940 40,069,996 40,071,211 Dof zinc finger protein 0 
GS-OH Bo8g114490 40,339,385 40,341,155 
2-oxoglutarate (2OG) and Fe(II)-dependent oxygenase 
superfamily protein 
2.84E-44 
Chromosome 9           
ALK/OH Bo9g006240 1,403,914 1,405,348 2-oxyglutarate-dependent dioxygenase 2.00E-65 
MYB34 Bo9g014380 4,303,846 4,304,977 MYB domain protein 34-1 0 
Table 2.11 (cont.) 
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end Gene product/protein/enzyme E-value 
MYB28 Bo9g014610 4,435,723 4,437,065 MYB domain protein 28-2 0 
APK1 Bo9g022580 7,123,370 7,124,580 Adenylyl-sulfate kinase 2.03E-114 
SOT Bo9g028880 9,912,132 9,913,136 Sulfotransferase 5b 0 
FMO-GSOX Bo9g037180 12,714,112 12,719,960 Flavin-monooxygenase 5.44E-180 
SOT Bo9g043490 14,050,846 14,051,961 Sulfotransferase 5b 0 
SOT Bo9g050970 15,578,526 15,579,554 Sulfotransferase 5b 0 
BAT5 Bo9g094080 29,099,176 29,101,254 Bile acid:sodium symporter family protein 0 
CYP81 Bo9g131960 40,476,397 40,478,713 Cytochrome P450 0 
GSTF Bo9g161480 47,559,122 47,559,966 Glutathione S-transferase 6.32E-90 
MYB29 Bo9g175680 52,123,078 52,125,388 MYB domain protein 29-1 0 
CYP79 Bo9g177260 52,892,785 52,894,636 Cytochrome P450 0 
 





Table 2.11 (cont.) 
 68 
Chapter 3. QTL Analysis for the Identification of Candidate Genes Controlling Phenolic 
Compound Accumulation in Broccoli (Brassica oleracea L. var. italica) 
3.1 Abstract 
 Quantitative trait loci (QTL) analysis of phenolic compound accumulation was conducted 
in a broccoli mapping population (B. oleracea) saturated with single nucleotide polymorphism 
markers from an Illumina 60K array designed for rapeseed (B. napus). In two years of analysis in 
North Carolina and one year in Illinois, variation in total phenolic content and antioxidant 
capacity was associated with 52 QTL. 17 of these loci were identified in at least two analyses; 
the three most stable QTL (no. 7, no. 16, and no. 45) were identified in four analyses. Genome-
specific SNP markers were used to identify candidate genes within the QTL marker intervals. 
Genes involved in the early stages of phenylpropanoid biosynthesis and MYB transcription 
factors were most heavily represented among the putative candidate genes. The results 
demonstrate the complexity of the regulatory network involved in phenolic compound 
accumulation, but highlight potential targets for the development of Brassica vegetables with 
enhanced phenolic compound profiles.  
3.2 Introduction 
Phenolic compounds constitute the largest and most ubiquitous category of secondary 
metabolites across the plant kingdom, displaying a breadth of structural and functional diversity. 
Phenolic compounds are characterized by the presence of at least one aromatic ring with at least 
one hydroxyl group attached. Phenylpropanoid biosynthesis begins with the aromatic amino 
acids produced by the shikimate pathway. The genes and regulation of phenolic compound 
biosynthesis have been well characterized, and the reader is directed to two recent reviews for 
further detail (Cheynier et al. 2013; Saito et al. 2013). A generalized figure of the 
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phenylpropanoid biosynthesis pathway is presented in Figure 3.1. Studies of the phenolic profile 
of broccoli florets have shown that the primary phenolic compounds present are flavonol and 
hydroxycinnamic acid derivatives, with the most significant flavonol constituents of broccoli 
being quercetin and kaempferol (Price et al. 1997; Price et al. 1998; Heimler et al. 2006). 
Interest in examining the health benefits of phenolic compounds began largely due to 
epidemiological evidence that diets rich in flavonoids and other phenolic compounds were 
associated with a lower risk of coronary heart disease (Hertog et al. 1995), breast (Sun et al. 
2006), lung (Tang et al. 2009; Knekt et al. 2002), and prostate cancer, type II diabetes, and 
asthma  (Knekt et al. 2002). The role of reactive oxygen species (ROS) in chronic disease (Ma 
2014) and the strong ability of phenolic compounds to scavenge free radical in vitro led to the 
belief that this was a primary cause for the health benefits associated with their consumption 
(Masella et al. 2005). However, further investigation of the metabolism and disposition of 
phenolic compounds in humans revealed modest to low absorption and extensive conjugation 
and breakdown of phenolic metabolites (Clifford 2004; Bergman et al. 2010). Instead of direct 
radical scavenging, which would require phenolic metabolites to outcompete the native 
antioxidants, ascorbic acid and α-tocopherol, interaction with cellular signaling cascades is a 
much more plausible mode of action (Crozier et al. 2009). There is evidence that supports a role 
for phenolic compounds in interactions with a number of different signaling molecules, including 
NF-κB, cyclooxygenase-2, Nrf2, and MAP kinase cascades (Kim et al. 2015; Weng et al. 2011). 
Of these, the Nrf2/Keap1/ARE cascades is the best characterized. Nrf2 is a transcription factor 
that activates the expression of phase II detoxification enzymes (e.g. NAD(P)H: quinone 
reductase and glutathione-S-tranferase) by binding to antioxidant response element/ electrophile 
response element (ARE/EpRE) sequences in the promoter region of target genes. Under basal 
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conditions, Nrf2 is bound in the cytoplasm and targeted for ubiquitination by its negative 
regulator, Keap1 (Osburn and Kensler 2008). 
Although direct radical scavenging is not a likely mechanism of cytoprotection in vivo, 
the reactivity of phenolic compounds with free radicals is not irrelevant. The same structural 
features that most commonly contribute to in vitro radical scavenging activity—ortho- and para-
hyroquinone moieties—also react readily with Keap1 cysteine thiolates. Other polyphenols that 
initially lack an electrophilic α,β-unsaturated carbonyl can be oxidized by free radicals to 
generate a quinone capable of reacting with Keap1. This elegantly illustrates how it is possible 
for “antioxidant” and “prooxidant” phenolic compounds and metabolites to positively impact the 
cellular redox state—by inducing phase II detoxification genes through the Nrf2/Keap1/ARE 
signaling pathway (Dinkova-Kostova et al. 2001; Forman et al. 2014).  
In addition to interacting at Keap1, polyphenols have also been demonstrated to induce 
MAP kinase activity involved in Nrf2 stabilization, nuclear translocation, and DNA binding. 
Weng et al. (2011) showed that quercetin treatment of human hepatoma HepG2 cells induced 
Nrf2 phosphorylation by JNK, ERK, p38, and Akt and promoted greater nuclear translocation 
and DNA binding. This study also found a significant correlation between the in vitro 
antioxidant activity of several polyphenols and their ability to promote phase II detoxification 
gene expression. 
Therefore, quantification of phenolic compounds (or antioxidant capacity as a proxy for 
bioactive phenolic content) and elucidation of the genetic controls involved in their accumulation 
is an important step in the process of breeding Brasssica vegetables for enhanced human health-
promotion. In this work, three classic phenolic content and antioxidant capacity assays were 
utilized to phenotype a broccoli (B. oleracea L. var. italica (N = 9 CC)) mapping population (VI-
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158 × BNC) in order to identify quantitative trait loci (QTL) associated with variability in 
phenolic compound concentration in broccoli florets.  
The parents of this population—VI-158, a calabrese-type double haploid of the F1 hybrid 
“Viking”, and “Broccolette Neri e Cespulgio” (BNC), a broccolette neri (black broccoli) 
accession (PI 462209)—were selected for their contrasting phytochemical profiles (Kushad et al. 
1999; Brown et al. 2002) and crossed to produce an F2:3 mapping population (Brown et al. 2007). 
This population was recently saturated with single nucleotide polymorphism (SNP) markers 
from the Illumina 60K iSelect array designed for rapeseed (Brassica napus, N = 19 AACC) and 
anchored to the TO1000 B. oleracea reference sequence (Parkin et al. 2014) by genome-specific 
markers. This information was used to conduct QTL mapping of carotenoid and glucosinolate 
profiles and to identify putative candidate genes co-localizing with the QTL (Brown et al. 2014; 
Brown et al. 2015). The present effort extends similar analysis to phenolic compound 
accumulation in the same population. 
3.3 Materials and Methods 
3.3.1 Cultivation of Plant Material  
 The biparental broccoli population used in this project was developed as described by 
Brown et al. (2007).  The parents were VI-158, a calabrese-type double haploid of the F1 hybrid 
“Viking” by a broccolette neri (black broccoli) accession “Broccolette Neri e Cespulgio” (BNC), 
PI 462209.  Freeze-dried samples of 92 F2:3 families grown in two field replications in 2009 and 
2010 at North Carolina State University as described by Brown et al. (2014) were obtained from 
the Brown lab.   
 During the 2014 growing season, 115 F2:3 families from the VI-158 × BNC mapping 
population were grown at University of Illinois at Urbana-Champaign (UIUC).  Seeds were 
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planted on May 28 in 48-cell flats filled with Sunshine® LC1 (Sun Gro Horticulture, Vancouver, 
British Columbia, Canada) professional potting mix.  Seedlings were germinated in the Plant 
Science Lab greenhouse under a14h/10h and 25°C/15°C day/night temperature regime for three 
weeks, and then were hardened off in an outdoor ground bed for two weeks prior to 
transplanting.  The plants were transplanted on July 7 to the University of Illinois South Farm 
(40° 04’ 38.89” N, 88° 14’ 26.18” W) and irrigated by hand during establishment.   
The field design consisted of a randomized complete block design with three replications. 
Guard rows were planted around the experimental plot to avoid border effects. Within each 
replicate, rows of ten plants spaced approximately 0.3m apart were included for each family, 
with 0.6m between rows.  Broccoli heads were harvested between August 3 and October 23, with 
at least five heads collected from each replicate of each family.  Heads were cut to similar size 
and stalk proportions, flash frozen immediately after harvest, and stored at -20°C.  The florets 
were lyophilized, ground to a fine powder with a coffee grinder, and stored at -20°C prior to 
analysis. Because the families were segregating for maturity, multiple harvests were conducted 
to obtain heads at uniform maturity.  In instances where multiple harvests were required for a 
given replicate of a family, proportional dry weight per heads harvested on each date were 
pooled to create a bulk sample for the family replicate. Days to harvest (DTH) were calculated 
using the transplant date as day 0, with a family DTH value represented by the mean harvest date 
weighted by heads harvested per day.  
3.3.2 Aqueous Extraction 
Freeze-dried broccoli powder samples of 75 mg were extracted with 1.5 mL ddH2O in 2 mL 
microcentrifuge tubes (Fischer Scientific).  Tubes were vortexed and stored at room temperature 
in the dark for 24 hr. After incubation, the tubes were centrifuged for 4 min at 12,000 rpm, and 
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the supernatants transferred to new 2 mL tubes.  The supernatants were spun for another 2 
minutes and 200 µL aliquots were pipetted into 96-well plates.  
3.3.3 Total Phenolic Content 
 The phenolic content of aqueous broccoli extracts were quantified using the Folin-
Ciocalteu reagent (FCR) method as described by Ku et al. (2010), with minor modifications. 
Briefly, 10 µL of sample aqueous extract was pipetted into a 96-well plate, followed by 100 µL 
of 0.2M FCR.  After three minutes, 90 µL of saturated sodium carbonate solution was added to 
each well. The samples were incubated for 1 hour at room temperature, after which the optical 
density was measured at 630 nm on a BioTek EL 808 microplate reader (Biotek Instruments Inc., 
Power Wave XS, Winooski, VT). The total phenolic content was calculated using a gallic acid 
standard curve, with concentrations ranging from 31.25-500 µg/mL, and was reported as 
milligrams of gallic acid equivalents (GAE) per 100 g dry weight. Three analytical replications 
were measured for each biological replicate (field replicate).  
3.3.4 ABTS Radical Scavenging Assay 
 The antioxidant capacity of aqueous broccoli extracts was quantified by the 2,2’-azino-
bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) radical assay according to Ku et al. (2010).  
The ABTS radical solution was generated by the treatment of 7mM ABTS (aqueous) with 2.45 
mM potassium persulfate.  The mixture was then allowed to stand for 12-16 hr for full color 
development (dark blue-green).  The solution was diluted with phosphate buffered saline until 
the absorbance (measured at 630 nm) reached 1.0 ± 0.02 for use in the assay reaction. 10 µL of 
the aqueous sample extract was treated with 190 µL of 7mM ABTS.  The samples were 
incubated for 6 min at room temperature, and then optical density was read at 630 nm on a 
microplate reader.  The antioxidant capacity was calculated as millimolar 6-hydroxy-2,5,7,8-
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tetramethyl-chroman-2-carbonsäure (Trolox) equivalents per 100 g sample dry weight (TE), 
based upon a Trolox standard curve with concentrations ranging from 0.08 – 2.5 mM.  All tests 
were performed in triplicate. 
3.3.5 DPPH Radical Scavenging Assay 
 A second measure of the antioxidant capacity of aqueous broccoli extracts was taken 
using the 2,2-Diphenyl-1-picrylhydrazyl DPPH radical scavenging assay, according to Ku et al. 
(2010). Briefly, 0.5mM DPPH in 9:1 methanol:water was diluted with 90% methanol (100% 
methanol was used for 2009 and 2010) to an optical density of 1.0 ± 0.02 at 490 nm. Then 190 
µL of DPPH methanol solution was added to 10 µL of aqueous broccoli extract in a 96-well 
plate and incubated for 30 min at room temperature. The optical density was read at 490 nm and 
the antioxidant capacity calculated as mM Trolox equivalents per 100 g sample dry weight (TE), 
based on the same Trolox standard curve used in the ABTS assay. All tests were performed in 
triplicate.  
3.3.6 Statistical Analysis 
 Statistical analyses were conducted using JMP 12 software (SAS Institute, Cary, NC). 
Analysis of variance (ANOVA) was conducted for all traits with all factors considered fixed. 
The general linear model was yijklm =  µ + Gi  + Yj  + R(Y)jk  + E(Y)jl  + εijklm where y = the trait 
measurement associated with the individual ijklm,  µ = overall population mean, G = genotype 
(family), Y = year (macro environment), R(Y) = replication (block) within year, E(Y) = within 
year environment (days to harvest), ε = experimental random error. The interaction between 
genotype and year was not fitted because there were insufficient degrees of freedom to estimate 
the effect. F-tests of effect significance were obtained using the Standard Least Squares (SLS) 
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method. Pearson’s correlation coefficients were generated for all trait-by-year combinations 
using the Restricted Maximum Likelihood (REML) method. 
3.3.7 Identification of QTL 
 The linkage map used in this analysis was developed by Brown et al. (2014), with minor 
updates. It consists of 553 SNP markers from the Brassica napus (AACC) 60k Illumina iSelect 
array that are named according to the progenitor genome (“A” = B. rapa or “C” = B. oleracea) 
followed by the position of the SNP as referenced by the ‘Chiifu-401’ or ‘TO1000’ genome 
sequence, respectively. The map covers 435,229,440 bp of the 446,905,700-bp TO1000 
reference assembly (97%. MapQTL
® 
5 (Van Ooijen 2004) was used to identify QTL associated 
with TPC, ABTS, and DPPH assay results from 2009, 2010, and 2014. Analysis was conducted 
on the Z-transformation of the average F2:3 family values for each assay from each year. Initially, 
non-parametric single-factor analysis was performed using the Kruskal-Wallis test to select a 
group of markers that were subsequently evaluated using the program’s default settings for 
automated backward-elimination cofactor selection.  The resulting model was tested by non-
restricted multiple-QTL mapping (MQM) with the default settings adjusted to a scan distance of 
0.5 cM. The process was iterated several times to produce an optimal set of cofactors. The 
genome-wide LOD-score threshold value for declaring the presence of a QTL (P < 0.05) was 
estimated by 1000 permutations of bootstrapping for each phenotypic trait. Confidence intervals 
were set using a 2-LOD drop off on either side of the maximum score. A QTL was considered 
common between analyses if the confidence intervals overlapped.  
 Genes involved in flavonoid biosynthesis and regulation were identified by Blast 
searches in the TO1000 B. oleracea reference genome (personal communication Yu Chun Chiu 
and Allan Brown). The results of this analysis are provided in Table 3.5. Genes from this pool of 
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a priori candidates that co-localized within or adjacent to a significant QTL interval were 
declared putative candidates genes contributing to the QTL effect. 
3.4 Results  
3.4.1 Total Phenolic Content and Radical Scavenging Assays 
 Means, standard deviations, and ranges of TPC, ABTS, and DPPH assay results for the 
broccoli F2:3 families from three years of analysis are presented in Table 3.1. Frequency 
distributions of phenolic compound accumulation (from all three assays) approximated normality 
(Figure 3.2). The population response for the ABTS assay was consistent across the 2009 and 
2010 growing seasons, which were both conducted in North Carolina. The 2014 population from 
Illinois showed ABTS assay results with a tighter distribution and a lower mean (4628.0 ± 486.0 
TE) than the 2009 and 2010 populations (5838.7 ± 944.8 TE and 5870.7 ± 1015.8, respectively).  
DPPH assay results were similar across all three years, with the exception that in 2010 the 
minimuc of values extends lower (271−2317 TE) than in 2009 and 2014 (403−2566 TE and 
491−2328 TE, respectively). The results of the total phenolic content assay are not informative 
for absolute quantification because a fresh solution of 7% sodium carbonate was prepared in 
2014 that was more concentrated than the solution used for analysis in 2009 and 2010, resulting 
in a scalar difference in the response of samples to the assay. However, the relative response of 
samples in a given year was similar for all three years and rankings of high and low TPC among 
samples are meaningful.   
 Considerable variation was demonstrated for all traits and in all years, with significant 
genetic and environmental effects detected by ANOVA (Table 3.2). 28 out of 36 trait-year 
combinations were significantly correlated, with the highest correlation seen between ABTS 
2014 and DPPH 2014 (r = 0.7632) (Table 3.3). DPPH 2009 did not correlate with any of the 
 77 
2014 traits, and TPC 2010 and DPPH 2010 did not correlate with TPC 2014 and DPPH 2014. 
The final non-significant relationship was between TPC 2009 and DPPH 2014.       
3.4.2 QTL Associated with Phenolic Compound Accumulation 
 QTL analysis identified 52 loci associated with phenolic compound accumulation at or 
above the genome-wide LOD threshold (3.7 – 3.9) across all 9 B. oleracea chromosomes (Figure 
3.3). Of these, 17 QTL were detected in multiple analyses (Table 3.4). The three most consistent 
QTL, associated with four trait-years each, were no. 7, no. 16, and no. 45. No. 7 was located on 
chromosome 1 (C01) between markers Bn-C1-p40578360 and Bn-C1-p41497525, and accounted 
for 9.6 – 18.6% of the phenotypic variation in TPC 09, ABTS 09, DPPH 10, and TPC 14. The 
putative candidate gene MYB65 co-localized with QTL no. 7. On C03, Bn-C3-p28076430 and 
Bn_A03_20584351 flanked QTL no. 16. Associated with all three traits from 2014 and TPC 09, 
it accounted for 6.8 – 9.4% of the phenotypic variation. Five candidate genes were identified 
within the QTL no. 16 interval, specifically 4-coumarate:CoA ligase 5 (4CL5), PRODUCTION 
OF ANTHOCYANIN PIGMENT 1 (PAP1, aka MYB75), MYB7, MYB113, and MYB114. QTL 
no. 45 was identified on C08 between markers Bn-C8-p29068278 and Bn-C8-p32125534. It 
explained 9.9 – 17.6% of the phenotypic variation in TPC 09, ABTS 09, TPC 14, and DPPH 14. 
QTL no. 45 functioned primarily in an additive manner, with the positive allele contributed by 
the parent BNC. The candidate gene chalcone-flavanone isomerase 1 (CHI, aka 
TRANSPARENT TESTA 5 [TT5]) was identified within this interval at 29,634,423 bp.  
 Two QTL were identified that occurred in three trait-years each, namely, no. 34 and no. 
49. No. 34 was located on C06 between markers Bn-C6-p17633267 and Bn-C6-p31037793, 
explaining up to 19.5% of the variation in ABTS 10, ABTS 14, and DPPH 14. BNC contributed 
the positive allele at this locus, demonstrating an additive effect. The no. 34 interval contained 8 
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putative candidate genes, the most of any QTL. These genes included two copies of 
phenylalanine ammonia-lyase (PAL), two copies of 4CL, MYB93, CHI, TRANSPARENT 
TESTA 1 (TT1), and TT12. QTL no. 49 was located on C09 between markers Bn-C9-
p02086982 and Bn-C9-p03558943. It explained 6.1 – 13.4% of the phenotypic variation in 
ABTS 09, TPC 10, and TPC 14. The putative candidate AT5MAT (an HXXXD acyl-transferase) 
was identified within the no. 49 interval from 2,296,997 – 2,298,332 bp.        
 The remaining 12 QTL that were identified in multiple analyses were each detected 
twice. Their chromosomal distribution was as follows: 2 on C01, 1 on C02, 1 on C03, 3 on C04, 
3 on C05, 1 on C07, and 1 on C08. Notable among these was QTL no. 6 on C01. It explained 
23.4% and 28.2% of the phenotypic variation in DPPH 14 and TPC 09, the largest contribution 
of any single QTL. This QTL effect was additive in nature, and BNC was again the parent that 
contributed the positive allele. Two putative candidate genes, LDOX (leucoanthocyanidin 
dioxygenase, aka anthocyanidin synthase (ANS)) and AT4g22870 (leucoanthocyanidin 
dioxygenase-like protein) were identified in the interval of QTL no. 6 at 10,073,622 and 
10,073,708 bp, respectively. 
 Of the 52 total QTL, only 10 lacked an a priori candidate gene. These loci could contain 
novel regulators of phenolic compound accumulation that have not yet been reported. 
Phenylalanine ammonia-lyase was the most frequently identified a priori candidate gene, 
existing within 4 QTL regions (no. 21, no. 22, no. 24, no. 44). CHI (no. 34, no. 45, no. 52), 4CL 
(no. 16, no. 33, no. 44), and MYB101 (no. 12, no. 20, no. 23) were tied for second most frequent, 
each appearing within 3 QTL. As a gene family, the MYB transcription factors were most 
heavily represented among the identified candidate genes. 24 different MYB genes were 
identified within significant QTL intervals.  
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3.5 Discussion 
Characterization of the variation in total phenolic content and antioxidant capacity in the 
VI-158 × BNC broccoli mapping population corroborated the expectation that both genetic and 
environmental factors play a significant role in determining phenolic compound accumulation. 
The genetic factor (family) was highly significant (P < 0.001) in all three assays, which allowed 
for successful QTL mapping of this genetic effect.  
The DPPH assay appears to have been more prone to experimental error or was 
influenced by uncharacterized factors, as its R
2 
value in the ANOVA was only 0.42871. The 
most likely source of interference is the presence of soluble protein in the aqueous broccoli 
extracts that may be precipitated out in the methanol solution used in the DPPH assay. This issue 
was largely mitigated in the 2014 DPPH analysis by altering the solvent system from 100% 
methanol to a 9:1 methanol: water solution. This improvement is reflected in the highly 
significant correlation between the ABTS and DPPH results in 2014 (r = 0.7632). However, the 
paired correlation between the ABTS and DPPH results in each year of analysis suggests that 
similar effects were captured by both assays, albeit with less power by DPPH. 
For TPC and ABTS, both in-season environmental effects captured by the factor days to 
harvest (DTH) and the specific year/location environmental effect (the factor termed ‘year’) 
significantly contributed to the variation in ANOVA analysis. The DTH factor also made a 
significant contribution to the variation in DPPH. This highlights the importance of measuring 
phenolic content over multiple environments and years in order to capture genes that control 
phenolic accumulation in response to different environmental stimuli. To our knowledge, this is 
the first QTL mapping study of phenolic compound accumulation and antioxidant capacity 
conducted in a broccoli population over multiple environments. Analysis of the VI-158 × BNC 
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mapping population is particularly powerful due to its dense genetic linkage map composed SNP 
markers anchored to the TO1000 rapid cycling Brassica oleracea reference sequence. 
 The identification of the putative candidate genes 4CL in QTL no. 16 and CHI in QTL 
no. 45, which were two of the three most consistent loci, is encouraging because it suggests that 
the influence of these early phenylpropanoid biosynthesis genes is stable across environments. In 
addition to these stable loci, copies of 4CL and CHI were each identified within a total of three 
separate QTL regions. PAL, the gene responsible for the first committed step in phenylpropanoid 
biosynthesis, was a putative candidate within four different loci, two of which were identified in 
two trait-years. The remaining 3 of the first 6 enzymes involved in flavonoid biosynthesis were 
also identified as putative candidates within at least one QTL. Cinnamic acid 4-hyrdoxylase 
(C4H) was identified within no. 12 and no. 23, chalcone synthase (CHS aka TT4) co-localized 
with no. 8, and flavanone 3-hydroxylase (F3H) was identified within no. 38 and no. 46. These 
results are consistent with another recent QTL mapping study of antioxidant activity in a rapid 
cycling B. oleracea × B. oleracea var. italica population that identified 4CL and other 
phenylpropanoid biosynthesis genes as QTL candidates (Sotelo et al. 2014a). The frequency of 
co-localization of significant QTL with core phenylpropanoid biosynthesis genes, especially 
PAL, 4CL, and CHI, suggests the presence of useful genetic variation within these genes that can 
be leveraged to make breeding progress.  
 While the biosynthetic genes are clearly of importance, this analysis presents stark 
evidence that an array of transcription factors play a major role in determining phenolic 
compound accumulation. 24 MYB transcription factors, a WRKY transcription factor, and a 
WD40 repeat protein—known to complex with MYBs—were all identified as putative 
candidates. This complexity is not surprising given the diverse roles of phenolic compounds in 
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plant survival. The regulatory effect of PAP1 (MYB75) is a good illustration of the integration of 
environmental signals in phenolic compound biosynthesis. Induction of PAP1 expression has 
been demonstrated in response to high light conditions and nitrogen and phosphorous depletion. 
Downstream targets activated by PAP1 include 20 flavonoid biosynthesis genes, resulting in 
accumulation of flavonoids in response to abiotic stress (Lotkowska et al. 2015). PAP1 was 
identified as a candidate gene within QTL no. 16 (consistent across four analyses), along with 
three other known activators of phenylpropanoid biosynthesis (MYB7, MYB113, and MYB114). 
One intriguing example that emerged from this research is the identification of MYB65 
as the putative candidate gene underlying QTL no. 7, which was identified in four analyses that 
included all three years (TPC 09, ABTS 09, DPPH 10, and TPC 14). MYB65 has close 
homology to the barley transcription factor GAMYB, which is known to transduce gibberellin 
signaling. In Arabidopsis, MYB65 has been shown to play a role in anther development, with its 
primary expression localized to the floral tissue (Millar and Gubler 2005). This is interesting 
because phenolic compounds are known to be important constituents of pollen grain walls 
(Quilichini et al. 2014) and because floral tissue is the major consumed portion of broccoli. The 
role of phenolic compounds in plant development logically necessitates the regulation of their 
biosynthesis in coordination with developmental programing.  
With an eye towards crop improvement, the involvement of such a complex regulatory 
network may at first glance appear to hinder the ability of breeders or producers to enhance 
phenolic compound accumulation. However, overexpression or repression of MYB activity 
through the use of transgenes and miRNA systems have the potential to profoundly change 
phenolic profiles in Brassica vegetables. Proof of concept has been demonstrated in tomato, 
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where over-expression of AtMYB12 has been shown to up-regulate the biosynthesis of 
caffeoylquinic acids and flavanols (Luo et al. 2008).  
While substantial environmental effects on phenolic compound accumulation is a 
challenge for consistency in the performance of field-grown crops, it also provides the 
opportunity for cultural practices to impact phenolic compound accumulation. An even greater 
impact may be seen in controlled environment systems such as greenhouse production, where the 
manipulation of light could be used to enhance phenolic compound accumulation. This is 
particularly relevant for specialty market production, as for broccoli sprouts, which may be 
marketed and sold at a premium for enhance health-promoting phytochemical composition.  
The results of this study highlight a number of targets for the enhancement of phenolic 
compound accumulation in Brassica cultivars.  While SNP markers from the QTL could be used 
for immediately marker-assisted selection, fine mapping of these QTL is needed to provide 












3.6 Figures and Tables 
Figure 3.1 A generalized phenylpropanoid biosynthesis pathway (Saito et al. 2013)
 
Figure 3.1 PAL, phenylalanine ammonia-lyase; C4H, cinnamic acid 4-hydroxylase; 4CL, 4-coumaric acid: CoA ligase; ACC, 
acetyl-CoA carboxylase; CHS, chalcone synthase; CHI, chalcone isomerase F3H, flavanone 3-hydroxylase; F3′H, flavonoid 
3′-hydroxylase; FLS, flavonol synthase; OMT1, O-methyltransferase 1; DFR, dihydroflavonol 4-reductase; ANS, 
anthocyanidin synthase; ANR, anthocyanidin reductase. 
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Figure 3.2 Frequency distribution of total phenolic content (TPC; mM gallic acid equivalents/ 100g DW), ABTS radical scavenging 
and DPPH radical scavenging (mM Trolox equivalents/ 100g DW) traits in the VI-158 × BNC F2:3 population over three years  
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Figure 3.3 Results of QTL mapping presented as line plots of LOD-score vs. chromosomal position (cM) for A: TPC, B: ABTS, and 
C: DPPH analyses over three years  
A 
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Figure 3.3 (cont.) 
B 
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Figure 3.3 (cont.) 
C 
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Table 3.1 Means, standard deviations, and ranges of the total phenolic content (TPC), ABTS 
radical scavenging capacity (ABTS), and DPPH radical scavenging capacity (DPPH) from floret 
tissue of the F2:3  VI-158 × BNC broccoli population over three years of analysis 
Assay Mean ± SD Range 
TPC 
  
2009 366.5 ± 26.6a 298−437 
2010 370.9 ± 26.4 313−463 
2014 857.1 ± 83.4 665−1185 
ABTS 
  
2009 5838.7 ± 944.8b 3610−9359 
2010 5870.7 ± 1015.8 3732−9608 
2014 4628.0 ± 486.0 3689−6245 
DPPH 
  
2009 1256.0 ± 376.6 403−2566 
2010 1107.6 ± 417.3 271−2317 
2014 1204.3 ± 336.2 491−2328 
 
a 
TPC expressed as gallic acid equivalents/100 g DW 
b 
ABTS and DPPH expressed as mM Trolox equivalents/100 g DW 
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Table 3.2 Analysis of variance of total phenolic content (TPC), ABTS radical scavenging capacity 
(ABTS), and DPPH radical scavenging capacity (DPPH) from floret tissue of the F2:3  VI-158 × 
BNC broccoli population evaluated in 2009 and 2010 in North Carolina and 2014 in Illinois. 
Values presented are sums of squares. 
Source TPC ABTS DPPH 
Family 9.94e5* 1.73e8** 3.81e7** 
Rep (Year) 1.74e4 3.43e6 2.69e6** 
DTH (Year) 1.25e5** 2.81e7** 2.77e6** 
Year 5.59e6** 8.35e7** 5.23e5 
Error 2.77e6 2.37e8 7.27e7 
R2 0.94 0.70 0.43 
* and ** are significant at P < 0.05 and P < 0.01, 
respectively   
 
Table 3.3 Pearson’s correlation coefficients (r) between individual trait-years measured in the F2:3  
VI-158 × BNC broccoli population 
  ABTS 09 DPPH 09 TPC 10 ABTS 10 DPPH 10 TPC 14 ABTS 14 DPPH 14 
TPC 09 0.535** 0.499** 0.559** 0.226** 0.260** 0.147* 0.169* 0.094 
ABTS 09 
 
0.525** 0.323** 0.584** 0.250** 0.231** 0.263** 0.302** 
DPPH 09 
  
0.342** 0.234** 0.345** 0.034 0.110 0.039 
TPC 10 
   
0.560** 0.410** 0.126 0.182** 0.101 
ABTS 10 
    
0.500** 0.273** 0.313** 0.292** 
DPPH 10 
     
0.102 0.196** 0.082 
TPC 14 
      
0.506** 0.550** 
ABTS 14         0.763** 
* and ** are significant at P < 0.05 and P < 0.01, respectively 





Table 3.4 QTL linkage map locations, flanking SNP markers, allele effects, phenotypic variation explained by the QTL, and candidate 











μ_A μ_H μ_B %P Putative Candidates 
1 ABTS 09 C01 2.6 Bn-C1-p00029741 Bn-C1-p00370644 5.11 -0.11 0.75 0.14 15.2 MYB4 
2 DPPH 09 C01 13.7 Bn-C1-p01703986 Bn-C1-p01789416 4.8 0.06 0.73 -1.07 12.1 
 3 ABTS 10 C01 15.5 Bn-C1-p01923307 Bn-C1-p02090899 4.45 0.02 0.65 0.08 8.6 MYB7, HCT 
3 DPPH 09 C01 16.5 Bn_A01_01422384 Bn-C1-p02340807 3.83 -1.53 -1.42 0.56 8.8 MYB7, HCT 
4 ABTS 10 C01 40 Bn_A01_04948316 Bn-C1-p07392382 4.61 -0.47 -0.15 0.57 8.8 
 5 ABTS 14 C01 42.7 Bn-C1-p08800375 Bn-C1-p09517731 7.65 -0.65 -0.09 0.67 16.9 MYB92 
6 DPPH 14 C01 44.2 Bn-C1-p09517731 Bn-C1-p11794504 14.27 -0.47 0.10 1.26 23.4 LDOX, AT4g22870 
6 TPC 09 C01 44.7 Bn_A01_06679669 Bn-C1-p12003811 12.25 0.37 -0.58 1.08 28.2 LDOX, AT4g22870 
7 TPC 14 C01 71.9 Bn-C1-p40578360 Bn-C1-p41034424 7.26 -0.42 -0.42 0.28 9.6 MYB65 
7 ABTS 09 C01 72.3 Bn-C1-p40875666 Bn-C1-p41170721 4.96 -0.49 0.28 0.57 13.6 MYB65 
7 DPPH 10 C01 74.7 Bn-C1-p41034424 Bn-C1-p41497525 7.11 -0.92 0.08 -0.42 12.1 MYB65 
7 TPC 09 C01 74.7 Bn-C1-p41034424 Bn-C1-p41497525 8.63 0.60 1.80 0.96 18.6 MYB65 
8 ABTS 10 C02 23.5 Bn-C2-p02890787 Bn-C2-p03659632 6.03 0.61 0.22 -0.51 12.1 TT4 (CHS) 
8 TPC 10 C02 23.5 Bn-C2-p02868435 Bn-C2-p02971211 11.85 0.13 -0.14 -1.38 19.1 TT4 (CHS) 
9 DPPH 10 C02 55.4 Bn-C2-p42194925 Bn-C2-p43425491 4.97 -1.12 -0.73 -0.22 9 
 10 ABTS 14 C03 23.4 Bn-C3-p04651804 Bn_A03_04180932 3.97 -0.39 0.06 0.41 8.1 
 11 ABTS 10 C03 29.5 Bn-C3-p05308401 Bn-C3-p06280470 4.61 -0.38 0.22 0.48 8.8 MYB48/59 
11 DPPH 10 C03 30.5 Bn-C3-p05308401 Bn-C3-p06280470 6.05 -1.06 -1.03 -0.16 10.8 MYB48/59 
12 DPPH 14 C03 37.7 Bn_A03_05866896 Bn-C3-p10393377 13.03 -0.20 0.67 0.99 20.9 MYB49/101, OMT1, C4H 
13 TPC 14 C03 41.8 Bn-C3-p10393377 Bn-C3-p12420975 6.23 -0.74 -0.13 0.64 8.7 UGT73C6, TTG2, CAC3 
14 TPC 14 C03 48.4 Bn-C3-p13064413 Bn_A03_10081359 4.24 0.56 0.26 -0.69 5.2 CYP98A3 
15 TPC 14 C03 58.6 Bn_A03_11772387 Bn_A03_12737336 6.79 -0.76 -0.49 0.62 9.1 MYB6 
16 TPC 14 C03 81.3 Bn-C3-p28076430 Bn-C3-p32296708 5.22 0.16 0.50 -0.32 6.8 4CL5, PAP1, MYB7/113/114 
16 ABTS 14 C03 82.1 Bn-C3-p28076430 Bn-C3-p32296708 4.32 -0.38 0.32 0.36 9.4 4CL5, PAP1, MYB7/113/114 
16 TPC 09 C03 85.5 Bn-C3-p28076430 Bn-C3-p33785454 4.77 0.35 1.01 1.25 8.8 4CL5, PAP1, MYB7/113/114 
16 DPPH 14 C03 86.2 Bn-C3-p32296708 Bn_A03_20584351 5.81 -0.19 0.08 0.96 7.9 4CL5, PAP1, MYB7/113/114 
17 TPC10 C03 114.1 Bn-C3-p57296637 Bn-C3-p60769039 4.87 -0.19 -0.56 -1.05 7.3 MYB48/59 
18 TPC 14 C04 9.7 Bn-C4-p01549566 Bn-C4-p02381936 4.51 0.20 0.32 -0.35 5.3   
18 ABTS 14 C04 10.2 Bn-C4-p01549566 Bn-C4-p02381936 4.5 0.44 0.35 -0.40 9.4   
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19 TPC 10 C04 13.9 Bn-C4-p02440944 Bn-C4-p02943481 4.12 -0.15 -0.43 -1.09 5.7 
 20 DPPH 10 C04 40.1 Bn-C4-p10349525 Bn-C4-p11015238 4.14 -0.64 -0.08 -0.69 7.2 MYB101 
21 TPC 09 C04 49.9 Bn-C4-p37595206 Bn-C4-p38747703 6.85 0.68 2.30 0.89 14.7 PAL3 
22 TPC 14 C04 54.1 Bn-C4-p45767999 Bn-C4-p43279394 7.72 0.36 -0.44 -0.50 10.5 UF3GT, PAL4 
22 TPC 09 C04 54.3 Bn-C4-p42892908 Bn_A04_13116453 6.74 -0.29 -0.52 1.86 12.3 UF3GT, PAL4 
23 DPPH 10 C04 58.1 Bn-C4-p45821281 Bn-C4-p46609817 4.43 -0.96 -1.25 -0.38 7.6 C4H, MYB101 
24 TPC 09 C04 66.7 Bn-C4-p49547471 Bn-C4-p50153979 5.87 1.64 0.58 -0.06 10.7 PAL1/2 
25 TPC 10 C04 77.8 Bn-C4-p51056930 Bn-C4-p51701964 5.76 -1.13 -0.91 -0.11 8.1 CYP98A3 
26 DPPH 14 C04 83.9 Bn-C4-p52177780 Bn-C4-p52368561 10.75 0.92 0.79 -0.11 16.1   
26 DPPH 10 C04 85.1 Bn-C4-p52225633 Bn-C4-p52368561 4.56 -1.13 -0.42 -0.04 7.5   
27 DPPH 09 C05 32.1 Bn-C5-p02588197 Bn-C5-p04170795 5.05 -1.24 0.11 0.27 15.3 CAC2 
27 TPC 10 C05 37.2 Bn-C5-p04170795 Bn-C5-p04997700 3.92 -0.96 -0.28 -0.28 5.1 CAC2 
28 DPPH 10 C05 40.7 Bn-C5-p05223886 Bn-C5-p07277640 4.28 -0.42 -1.15 -0.92 7.1 MYB63 
28 DPPH 09 C05 44.1 Bn-C5-p07277640 Bn-C5-p08047780 4.32 0.38 -0.66 -1.35 13 MYB63 
29 TPC 10 C05 62.7 Bn-C5-p40304729 Bn-C5-p41959864 4.79 -0.36 -0.09 -0.89 6 BGLU10 
29 TPC 14 C05 62.7 Bn-C5-p40304729 Bn-C5-p41959864 6.85 0.23 -0.49 -0.37 9.1 BGLU10 
30 TPC 09 C06 3.7 Bn-C6-p00315140 Bn-C6-p01409673 4.4 1.17 0.31 0.48 9.1 MYB63 
31 TPC 09 C06 29.5 Bn-C6-p03032332 Bn-C6-p03981788 7.43 0.08 0.48 1.48 14.7 MYB95, MYBL2 
32 ABTS 09 C06 44.6 Bn-C6-p06726844 Bn-C6-p07241341 5.37 -0.33 -0.62 0.48 17.1 AT1g24735, CCOAMT 
33 TPC 10 C06 47.3 Bn-C6-p07628656 Bn_A07_14975152 9.08 -0.89 -1.40 -0.29 13.6 4CL3, MYB62 
34 DPPH 14 C06 62.6 Bn-C6-p17633267 Bn-C6-p20200556 4.25 0.07 0.25 0.72 5.3 
PAL1/2, MYB93, TT12/1/5, 
4CL1/2 
34 ABTS 10 C06 63 Bn-C6-p19506663 Bn-C6-p31037793 9 -0.67 -0.23 0.77 19.5 
PAL1/2, MYB93, TT12/1/5, 
4CL1/2 
34 ABTS 14 C06 63.5 Bn-C6-p19506663 Bn-C6-p31037793 3.93 -0.38 -0.25 0.45 8.5 
PAL1/2, MYB93, TT12/1/5, 
4CL1/2 
35 TPC 14 C07 3.4 Bn-C7-p13115130 Bn-C7-p14997616 6.96 -0.29 -0.71 0.15 8.9 AT1g24735 
36 DPPH 10 C07 24.6 Bn_A06_22938934 Bn-C7-p33366127 7.09 -1.25 -0.25 -0.08 12.2 
 37 DPPH 10 C07 35.9 Bn-C7-p35347848 Bn-C7-p36343153 9.69 0.49 -0.31 -1.83 18.4 MYB111 
38 DPPH 14 C07 46.1 Bn-C7-p39438047 Bn-C7-p40890433 6.95 0.86 0.77 -0.08 10.3 F3H 
39 DPPH 10 C07 51.4 Bn-C7-p41241233 Bn-C7-p43333164 10.48 -1.67 -1.35 0.33 20.5 LDOX, AT4g22870  
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Chr., Chromosome number; Pos., most likely position for QTL on chromosome (cM); M1, Front flanking SNP marker; M2, Back 
flanking SNP marker; LOD, Logarithm of the odds; μ_A, mean for homozygous QTL marker allele from parent 1 (VI-158); μ_H, 
mean for heterozygous QTL marker allele; μ_B, mean for homozygous QTL marker allele from parent 2 (BNC); %P, percent of the 
phenotypic variation explained by the QTL (overestimated for linked QTL)  
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39 TPC 14 C07 54.7 Bn-C7-p43333164 Bn-C7-p44016812 4.78 0.15 0.32 -0.30 5.7 LDOX, AT4g22870  
40 DPPH 09 C07 59.1 Bn-C7-p44043402 Bn-C7-p44512932 4.11 -1.06 -0.70 0.04 11.4 OMT1 
41 TPC 10 C07 62.3 Bn-C7-p44529761 Bn-C7-p45406477 5.15 -0.81 -0.10 -0.43 6.8 
 42 TPC 10 C08 6.3 Bn-C8-p15189574 Bn-C8-p19415560 6.55 -0.41 -1.53 -0.83 9.5 
 43 DPPH 10 C08 13.6 Bn_A08_19541990 Bn-C8-p21602272 4.26 -0.85 -0.04 -0.49 6.5 AHA10 
44 DPPH 09 C08 23 Bn-C8-p25706196 Bn-C8-p27802012 4.18 -0.79 0.11 -0.32 11.9 MYB84/77 
44 TPC 10 C08 24 Bn-C8-p25706196 Bn-C8-p27802012 13.07 -1.36 0.31 0.06 21.5 MYB84/77 
45 DPPH 14 C08 28.9 Bn-C8-p29068278 Bn-C8-p30785808 7.44 -0.03 0.03 0.82 10.4 TT5 
45 TPC 09 C08 31.4 Bn-C8-p29395056 Bn-C8-p31688245 8.7 0.33 1.44 1.24 17.6 TT5 
45 TPC 14 C08 33.2 Bn-C8-p30785808 Bn-C8-p31898562 7.32 -0.53 -0.09 0.39 9.9 TT5 
45 ABTS 09 C08 34.2 Bn-C8-p31688245 Bn-C8-p32125534 4.93 -0.46 0.26 0.54 13.9 TT5 
46 ABTS 10 C08 40.3 Bn-C8-p35741949 Bn-C8-p35982715 8.34 -0.61 -0.08 0.71 17.7 F3H 
47 ABTS 14 C08 53.6 Bn-C8-p37703534 Bn-C8-p38577059 4.03 -0.48 0.01 0.48 8.8 TTG1 
48 TPC 09 C08 60.6 Bn-C8-p39998098 Bn-C8-p40317098 5.56 0.70 -0.01 0.84 9.1 MYB50, AT1g06000 
49 TPC 14 C09 8.4 Bn-C9-p02086982 Bn-C9-p02689607 7.19 -0.29 0.49 0.15 9.5 AT5MAT 
49 TPC 10 C09 11.5 Bn-C9-p02309674 Bn-C9-p02919300 4.51 -0.11 -0.42 -1.13 6.1 AT5MAT 
49 ABTS 09 C09 13.6 Bn-C9-p02689607 Bn-C9-p03558943 4.55 -1.90 -0.45 2.15 13.4 AT5MAT 
50 TPC 09 C09 27.4 Bn_A09_02730673 Bn-C9-p05218392 4.13 1.25 0.53 0.37 7.5 MYB96/94, HCS1 
51 TPC 10 C09 41.1 Bn-C9-p05218392 Bn-C9-p08945466 3.87 -0.90 -0.17 -0.52 6.2 MYB84 
52 TPC 10 C09 93.1 Bn-C9-p51460548 Bn-C9-p52270996 10.19 -0.20 -1.38 -0.90 16.9 TT5 
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3.7 Supplemental Table 
Table 3.5 Flavonoid biosynthesis pathway genes: Blast results of Brassica oleracea TO1000 reference genome with Arabidopsis 
genes as queries (Allan Brown and Yu Chun Chiu, personal communication) 
Gene name E-value Chr. Hit start Hit end Gene Description 
MYB4 2.58E-141 C1 65,247 65,867 MYB domain protein 
MYB73 0 C1 1,029,371 1,028,122 MYB domain protein 
MYB7 2.12E-134 C1 2,145,205 2,144,201 MYB domain protein 
HCT 0 C1 2,190,114 2,188,965 
hydroxycinnamoyl-CoA shikimate/quinate hydroxycinnamoyl 
transferase 
MYB92 3.83E-32 C1 8,843,225 8,842,644 MYB domain protein 
LDOX 0 C1 10,073,622 10,074,304 leucoanthocyanidin dioxygenase 
AT4g22870 8.36E-139 C1 10,073,708 10,074,055 leucoanthocyanidin dioxygenase-like protein 
AT4g26220 0.00E+00 C1 13,156,613 13,155,667 putative caffeoyl-CoA O-methyltransferase 
HCT 0 C1 16,175,627 16,177,074 
hydroxycinnamoyl-CoA shikimate/quinate hydroxycinnamoyl 
transferase 
MYB77 1.76E-167 C1 24,097,872 24,098,865 anthocyanidin reductase 
BAN 0 C1 29,095,678 29,096,566 anthocyanidin reductase 
UGT73C6 0 C1 31,877,798 31,878,838 flavonol 7-O-glucosyltransferase 
MYB65 0 C1 40,270,093 40,268,648 MYB domain protein 
MYB92 0 C2 2,132,152 2,133,724 MYB domain protein 
TT4 0 C2 3,150,764 3,151,800 chalcone synthase 
CAC1 3.65E-167 C2 3,959,366 3,960,073 Biotin carboxyl carrier protein of acetyl-CoA carboxylase 
UGT78D3 0 C2 4,164,913 4,165,801 flavonol 3-Oarabinosyltransferase 
UGT78D2 0 C2 4,164,922 4,166,506 flavonoid 3-O-glucosyltransferase 
UGT78D1 0 C2 4,165,832 4,164,920 flavonol 3-Orhamnosyltransferase 
GSTF12 0 C2 4,208,251 4,209,069 Glutathione S-transferase 
BAN 0 C2 4,774,651 4,775,539 anthocyanidin reductase 
MYB48 1.49E-155 C2 7,698,183 7,699,139 MYB domain protein 
MYB59 0 C2 7,699,291 7,698,207 MYB domain protein 
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HCS1 0 C2 16,995,124 16,996,854 Holocarboxylase synthase 1 
MYB62 0 C2 17,108,592 17,109,656 MYB domain protein 
MYBL2 2.69E-102 C2 20,553,476 20,553,954 MYB domain protein 
MYB95 1.32E-115 C2 22,790,350 22,791,033 MYB domain protein 
DFR 1.64E-176 C2 35,464,024 35,464,714 dihydroflavonol-4-reductase 
TT4 0 C2 47,363,844 47,365,190 chalcone synthase 
MYB50 3.49E-69 C2 49,093,424 49,092,841 MYB domain protein 
TT16 0 C2 50,416,068 50,414,772 MADS-box transcription factor 
MYB96 0 C2 51,286,692 51,288,646 MYB domain protein 
MYB94 1.04E-109 C2 51,287,267 51,287,991 MYB domain protein 
MYBR1 0 C2 52,638,254 52,639,174 MYB domain protein r1 
MYB84 9.74E-128 C2 52,778,442 52,777,488 MYB domain protein 
MYB92 0 C3 2,152,964 2,154,504 MYB domain protein 
TT4 0 C3 3,213,136 3,214,294 chalcone synthase 
CAC1 1.05E-167 C3 3,957,862 3,958,614 Biotin carboxyl carrier protein of acetyl-CoA carboxylase 
MYB48 1.15E-150 C3 5,828,128 5,829,101 MYB domain protein 
MYB59 0 C3 5,829,255 5,828,149 MYB domain protein 
MYB49 0.00E+00 C3 7,635,517 7,634,085 MYB domain protein 
OMT1 0 C3 7,675,163 7,674,142 caffeic acid/5-hydroxyferulic acid O-methyltransferase 
C4H 0 C3 9,243,341 9,244,339 trans-cinnamate 4-monooxygenase 
MYB101 0 C3 9,829,153 9,830,596 MYB domain protein 
UGT73C6 0 C3 11,494,206 11,495,766 flavonol 7-O-glucosyltransferase 
TTG2 0 C3 11,768,398 11,769,931 WRKY transcription factor 
CAC3 0 C3 12,117,511 12,120,336 carboxyltransferase alpha subunit 
CYP98A3 0 C3 13,643,607 13,644,424 cytochrome P450 98A3 
CPC 5.22E-73 C3 15,654,011 15,654,337 MYB transcription factor 
MYB12 0 C3 15,959,548 15,960,660 PFG1 
Table 3.5 (cont.) 
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LAP6 0 C3 17,180,760 17,179,523 hydroxyalkyl-a-pyrone synthases 
MYB6 3.20E-95 C3 18,178,768 18,179,266 MYB domain protein 
TT4 0 C3 20,970,229 20,969,575 chalcone synthase 
MYB59 1.38E-156 C3 24,040,679 24,040,235 MYB domain protein 
4CL5 0 C3 29,045,701 29,046,788 4-coumarate:CoA ligase 
PAP1 4.65E-170 C3 30,323,862 30,324,635 MYB domain protein 
MYB113 8.30E-133 C3 30,324,629 30,323,891 MYB domain protein 
MYB114 3.69E-87 C3 30,324,635 30,324,228 MYB domain protein 
MYB7 0 C3 33,353,182 33,354,220 MYB domain protein 
MYB84 5.39E-112 C3 35,015,200 35,014,212 MYB domain protein 
MYB92 7.36E-149 C3 35,634,483 35,633,481 MYB domain protein 
FLS3 6.21E-67 C3 36,933,268 36,934,028 flavonol synthase 
FLS5 2.29E-54 C3 36,933,313 36,934,042 flavonol synthase 
FLS6 4.66E-36 C3 36,934,083 36,933,701 flavonol synthase 
MYB94 1.11E-115 C3 38,072,530 38,071,785 MYB domain protein 
MYB96 0 C3 38,072,966 38,071,120 MYB domain protein 
MYB48 0 C3 47,845,476 47,846,559 MYB domain protein 
MYB59 7.15E-173 C3 47,846,454 47,845,507 MYB domain protein 
CCOAMT 8.30E-91 C3 50,593,051 50,592,282 caffeoyl-CoA 3-O-methyltransferase 
AT1g24735 0 C3 50,593,058 50,592,277 
S-adenosyl-L-methionine-dependent methyltransferases 
superfamily protein 
MYB4 0 C3 53,229,583 53,230,963 MYB domain protein 
MYB73 0 C3 54,865,650 54,864,700 MYB domain protein 
LAP5 0 C3 59,219,010 59,217,658 hydroxyalkyl-a-pyrone synthases 
CCoAOMT1 0 C3 59,775,453 59,774,737 putative caffeoyl-CoA O-methyltransferase 
MYB12 3.34E-150 C4 312,979 311,850 PFG1 
CAC3 0 C4 6,195,503 6,192,766 carboxyltransferase alpha subunit 
TTG2 0 C4 6,798,921 6,797,453 WRKY transcription factor 
PAL2 0 C4 6,918,011 6,916,253 Phenylalanine ammonia-lyase 
PAL1 0 C4 6,918,205 6,916,215 Phenylalanine ammonia-lyase 
UGT73C6 0 C4 7,127,826 7,129,358 flavonol 7-O-glucosyltransferase 
Table 3.5 (cont.) 
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MYB101 0 C4 10,822,532 10,824,141 MYB domain protein 
BAN 0 C4 21,922,535 21,924,032 anthocyanidin reductase 
BGLU10 0 C4 24,625,053 24,626,518 beta glucosidase 
F3H 1.28E-120 C4 31,150,855 31,151,572 flavanone 3-hydroxylase 
PAL3 0 C4 39,789,183 39,787,280 Phenylalanine ammonia-lyase 
MYB73 2.83E-140 C4 41,372,374 41,371,577 MYB domain protein 
MYBR1 2.56E-149 C4 42,477,305 42,476,688 MYB domain protein r1 
UF3GT 0 C4 42,785,718 42,784,293 anthocyanidin 3-O-glucoside 2'''-O-xylosyltransferase 
PAL4 0 C4 42,909,255 42,908,027 Phenylalanine ammonia-lyase 
C4H 0 C4 45,817,991 45,819,080 trans-cinnamate 4-monooxygenase 
MYB101 0 C4 47,285,453 47,286,998 MYB domain protein 
UGT73C6 0 C4 49,436,052 49,437,550 flavonol 7-O-glucosyltransferase 
PAL1 0 C4 49,576,818 49,578,738 Phenylalanine ammonia-lyase 
PAL2 0 C4 49,576,975 49,578,736 Phenylalanine ammonia-lyase 
LAP6 0 C4 50,002,644 50,003,640 hydroxyalkyl-a-pyrone synthases 
CYP98A3 0 C4 51,295,513 51,296,380 cytochrome P450 98A3 
MYB12 0 C4 53,560,015 53,560,983 PFG1 
CAC2 4.68E-169 C5 4,064,143 4,064,946 Biotin carboxylase 
MYB63 2.83E-121 C5 7,908,667 7,907,642 MYB domain protein 
MYB51 1.41E-177 C5 8,865,184 8,865,971 MYB domain protein 51-2 
C4H 0 C5 17,278,895 17,277,897 trans-cinnamate 4-monooxygenase 
4CL2 2.38E-177 C5 32,640,314 32,639,586 4-Coumarate:CoA ligase 
4CL5 0 C5 32,808,090 32,806,957 4-coumarate:CoA ligase 
BGLU10 0 C5 41,306,916 41,308,457 beta glucosidase 
MYB65 0 C5 42,320,012 42,318,674 MYB domain protein 
PAL2 5.97E-159 C5 42,908,130 42,909,236 Phenylalanine ammonia-lyase 
PAL1 1.11E-149 C5 42,908,133 42,909,236 Phenylalanine ammonia-lyase 
PAL3 3.71E-175 C5 42,909,240 42,908,140 Phenylalanine ammonia-lyase 
GSTF12 3.37E-93 C5 46,212,478 46,211,629 Glutathione S-transferase 
MYB63 0 C6 598,634 597,652 MYB domain protein 
MYB95 4.92E-159 C6 2,754,596 2,753,333 MYB domain protein 
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MYBL2 0 C6 4,459,879 4,458,849 MYB domain protein 
MYB48 4.58E-86 C6 5,598,286 5,598,826 MYB domain protein 
MYB59 1.06E-170 C6 5,598,838 5,598,287 MYB domain protein 
MYB62 0 C6 6,690,812 6,689,711 MYB domain protein 
AT1g24735 4.15E-89 C6 6,838,491 6,837,743 
S-adenosyl-L-methionine-dependent methyltransferases 
superfamily protein 
CCOAMT 0 C6 6,838,499 6,837,611 caffeoyl-CoA 3-O-methyltransferase 
MYB113 2.23E-89 C6 7,910,630 7,910,126 MYB domain protein 
4CL3 0 C6 8,346,950 8,348,521 4-Coumarate:CoA ligase 
MYB62 0 C6 9,198,445 9,199,487 MYB domain protein 
MYB95 1.84E-145 C6 12,447,697 12,448,769 MYB domain protein 
MYB63 0 C6 14,839,300 14,840,325 MYB domain protein 
TT12 0 C6 17,693,700 17,691,946 Multi-drug and toxic efflux (MATE) transporter 
TT5 9.02E-71 C6 19,971,613 19,971,164 chalcone--flavonone isomerase 1 
PAL1 0 C6 21,198,354 21,196,562 Phenylalanine ammonia-lyase 
PAL2 0 C6 21,198,483 21,196,583 Phenylalanine ammonia-lyase 
MYB93 0 C6 28,144,712 28,145,565 MYB domain protein 
TT1 2.72E-148 C6 28,238,338 28,238,873 Transparent testa 1 
4CL1 0 C6 29,213,700 29,214,841 4-Coumarate:CoA ligase 
4CL2 0 C6 29,213,834 29,214,838 4-Coumarate:CoA ligase 
ACC2 0 C6 37,424,989 37,429,733 Acetyl-CoA carboxylase 
ACC1 0 C6 37,425,019 37,429,704 Acetyl-CoA carboxylase 
HCT 0 C7 443,605 442,131 
hydroxycinnamoyl-CoA shikimate/quinate hydroxycinnamoyl 
transferase 
AT1g24735 5.77E-100 C7 18,625,640 18,626,213 
S-adenosyl-L-methionine-dependent methyltransferases 
superfamily protein 
MYB77 3.89E-87 C7 23,748,948 23,749,545 MYB domain protein 
MYBR1 0 C7 23,749,543 23,748,500 MYB domain protein r1 
MYB111 0 C7 35,406,391 35,407,435 PFG3 
TTG1 0 C7 37,467,696 37,466,680 WD40-repeat protein 
TT16 0 C7 38,100,107 38,097,703 MADS-box transcription factor 
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MYB77 0 C7 38,893,182 38,894,111 MYB domain protein r1 
F3H 0 C7 39,275,950 39,276,798 flavanone 3-hydroxylase 
LDOX 0 C7 42,567,438 42,568,641 leucoanthocyanidin dioxygenase 
AT4g22870 5.28E-135 C7 42,567,449 42,567,795 leucoanthocyanidin dioxygenase-like protein 
OMT1 4.25E-141 C7 44,389,314 44,390,185 caffeic acid/5-hydroxyferulic acid O-methyltransferase 
CCoAOMT1 0 C7 46,566,626 46,567,922 putative caffeoyl-CoA O-methyltransferase 
BAN 6.01E-131 C7 46,714,851 46,714,256 anthocyanidin reductase 
LAP5 0 C7 46,808,559 46,809,165 Chalcone synthase 6 protein 
MYB7 4.99E-117 C7 46,820,933 46,821,853 MYB domain protein 
TT5 2.12E-91 C7 47,048,858 47,048,147 chalcone--flavonone isomerase 1 
MYB73 5.47E-143 C7 47,505,916 47,506,419 MYB domain protein 
MYB4 0 C7 48,236,752 48,235,255 MYB domain protein 
AT1g03940 0 C8 426,168 427,567 HXXXD-type acyl-transferase family protein 
AT1g03495 0 C8 427,567 426,156 HXXXD-type acyl-transferase family protein 
ACC2 0 C8 7,088,898 7,080,851 Acetyl-CoA carboxylase 
ACC1 0 C8 7,090,314 7,080,710 Acetyl-CoA carboxylase 
TT2 0 C8 9,666,955 9,665,869 MYB domain protein 
AT4g14090 0.00E+00 C8 12,988,163 12,989,587 UDP_Glycosyltransferase superfamily protein 
CCOAMT 1.15E-82 C8 13,297,996 13,297,219 caffeoyl-CoA 3-O-methyltransferase 
AT1g24735 0 C8 13,298,043 13,297,183 
S-adenosyl-L-methionine-dependent methyltransferases 
superfamily protein 
AHA10 0 C8 21,603,890 21,606,430 P-type Hþ-ATPase 
MYB51 0 C8 22,081,506 22,082,167 MYB domain protein 51-2 
MYB84 0 C8 25,938,269 25,939,228 MYB domain protein 
MYB77 0 C8 26,360,488 26,361,304 MYB domain protein r1 
F3H 0 C8 27,874,961 27,873,974 flavanone 3-hydroxylase 
PAL2 0 C8 28,496,455 28,498,327 Phenylalanine ammonia-lyase 
PAL1 0 C8 28,496,542 28,498,330 Phenylalanine ammonia-lyase 
TT5 1.98E-123 C8 29,634,423 29,635,131 chalcone--flavonone isomerase 1 
BGLU10 0 C8 33,536,146 33,534,253 beta glucosidase 
F3H 0 C8 34,187,738 34,186,658 flavanone 3-hydroxylase 
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MYB51 0 C8 36,561,631 36,561,009 MYB domain protein 51-2 
MYB63 1.06E-88 C8 37,174,509 37,175,057 MYB domain protein 
TTG1 2.10E-119 C8 38,421,236 38,420,490 WD40-repeat protein 
MYB50 7.69E-65 C8 39,602,853 39,602,468 MYB domain protein 
AT1g06000 0 C8 40,476,435 40,475,173 UDP_Glycosyltransferase superfamily protein 
MYB50 3.73E-56 C9 706,118 705,549 MYB domain protein 
TT4 0 C9 824,998 826,269 chalcone synthase 
AT5MAT 0.00E+00 C9 2,296,997 2,298,332 HXXXD-type acyl-transferase family protein 
TT16 0 C9 4,242,050 4,240,881 MADS-box transcription factor 
MYB96 0 C9 4,708,110 4,709,982 MYB domain protein 
MYB94 6.12E-138 C9 4,708,596 4,709,692 MYB domain protein 
HCS1 0 C9 4,789,663 4,788,254 Holocarboxylase synthase 1 
MYB84 3.64E-95 C9 6,039,473 6,040,179 MYB domain protein 
DFR 0 C9 17,116,309 17,117,942 dihydroflavonol-4-reductase 
UF3GT 0 C9 36,653,824 36,655,251 anthocyanidin 3-O-glucoside 2'''-O-xylosyltransferase 
OMT1 0 C9 36,851,026 36,851,986 caffeic acid/5-hydroxyferulic acid O-methyltransferase 
MYB59 0 C9 42,674,038 42,675,040 MYB domain protein 
MYB48 4.01E-112 C9 42,675,085 42,674,398 MYB domain protein 
GSTF12 0 C9 47,559,971 47,559,059 Glutathione S-transferase 
TT4 0 C9 49,233,309 49,231,891 chalcone synthase 
MYB92 0 C9 50,962,876 50,961,366 MYB domain protein 
TT7 0 C9 51,727,181 51,752,762 Flavonoid 3'-monooxygenase 
AT5g05270 9.84E-173 C9 52,891,399 52,890,359 Similarity to chalcone-flavonone isomerase 
Table 3.5 (cont.) 
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Chapter 4: Summary and Future Perspectives 
 The importance of diet in reducing the risk of chronic and degenerative disease is the 
major driver behind the development of functional foods—plant-based foods rich in health-
promoting phytochemicals. Brassica vegetables are an important source of a number of vitamins, 
minerals, and plant secondary metabolites the exhibit human health benefits. This research 
focused on glucosinolate hydrolysis products and phenolic compounds, two classes of secondary 
metabolites in Brassica crops that show strong potential for reducing the risk of certain cancers 
and other diseases. The objective of this research was to quantify variation in glucosinolate 
hydrolysis product profiles and phenolic compound accumulation and to identify genetic loci and 
candidate genes associated with this variation. 
In the first project presented from this study, an F2:3  broccoli mapping population (VI-
158 × BNC) was evaluated for variation in the hydrolysis of two exogenous glucosinolates using 
a gas chromatography system to quantify individual hydrolysis products. Considerable variation 
was observed among the F2:3  families for the total amount of hydrolysis products produced and 
the percent nitrile formation in all three growing seasons. However, when looking at individual 
GSs, there was not a significant difference in the hydrolysis of BZGS in 2009 and 2010 among 
the families. The whole population also showed a strong response to the growing season 
environments. All of the population-year means for hydrolysis product formation and percent 
nitrile formation were significantly different from one another, except for BZGS hydrolysis in 
2009 and 2010 (Tukey’s Honestly Significant Difference test, data not shown). Hydrolysis 
product formation and percent nitrile formation for both BZGS and SN were substantially greater 
when the population was grown in North Carolina (2009 and 2010) than when the population 
was grown in Illinois (2014). Following the characterization of variation in GS hydrolysis 
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product profiles attributed to genotype, QTL mapping was performed to identify genetic loci 
associated with this variation. Over all of the years and individual trait analyses, a total of 52 loci 
were associated at least one GS hydrolysis trait. Three QTL were particularly stable, showing 
significance in five analyses. Candidate genes that were identified within the QTL included 
known GS biosynthesis genes, transcription factors involved regulating GS biosynthesis, and 
genes involved in GS hydrolysis. 
Further research is required to validate these gene candidates, potentially by fine mapping 
and cloning the target genes. Another important research question raised in this study is the 
location of myrosinase genes in the B. oleracea genome. BLAST searches of Arabidopsis 
myrosinase gene queries were largely unsuccessful in identifying high-confidence hits in the 
TO1000 reference genome. Considering that multiple copies of myrosinase genes are expected to 
exist, further bioinformatics and molecular genetics research should be undertaken to locate and 
characterize the B. oleracea myrosinase genes. Other interesting work that could be conducted to 
follow up this study would be mining the QTL for previously unknown regulators of GS 
metabolism. Since the observed environmental impact on myrosinase activity and glucosinolate 
conversion into ITCs was considerable, another line of questioning could involve the 
identification of particular environmental variables that contribute to this effect.    
For the second project, three biochemical assays were employed to quantify variation in 
phenolic compound accumulation. The results of the total phenolic content assay, ABTS radical 
scavenging assay, and DPPH radical scavenging assay in a give year showed significant, but not 
perfect correlations with one another. This suggests that the different assay conditions, solvent 
systems, and reactive agents are able to capture slightly different portions of the phenolic profile 
of the broccoli samples. The variation in phenolic content in the VI-158 × BNC was attributed to 
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both genetic and environmental factors by ANOVA, as would be expected because of the role of 
phenolic compounds in mitigating environmental stress. QTL mapping of phenolic content 
variation over three years of analysis and three assays identified 52 significant QTL. Two 
important groups of genes were identified as candidates underlying these QTL effects. The first 
group was MYB transcription factors. 24 different MYBs were identified as candidate genes in 
at least one QTL. It is logical that these transcriptional regulators would play such an important 
role in the modulation of phenolic content in broccoli because of their key role in the 
transduction of environmental and developmental signals. Though this regulatory network is 
clearly complex, this study offers several MYB targets that were candidates underneath multiple 
QTL that could induce consistent effects on phenolic compound accumulation. The second group 
of important candidate genes was enzymes involved in the early stages of phenylpropanoid 
biosynthesis such as PAL, 4CL, and CHI. Genetic variation in biosynthesis gene alleles is of 
great significance because it means that gains from selection either through traditional breeding 
or marker-assisted selection are possible. Markers associated with these QTL could be utilized to 
evaluate breeding populations for variation in phenylpropanoid biosynthesis genes. 
Following this work, validation of the candidate genes could be conduced through fine 
mapping and cloning in order to confirm their effect on phenolic compound accumulation. 
Additionally, qRT-PCR could be used to measure transcript abundance of the putative candidates 
to test for correlation between changes in transcription and changes in phenolic profiles. 
Bioinformatics mining of the 10 QTL that did not contain a priori gene candidates could also be 
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